<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2026.1751497</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Flourishing and its influencing factor in inflammatory bowel disease patients: a latent profile analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Lu</surname><given-names>Bingyuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Ma</surname><given-names>Linlin</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3031839/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Xia</surname><given-names>Fei</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Lu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Ying</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname><given-names>Xiaoyan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sun</surname><given-names>Renjuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2748753/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Luo</surname><given-names>Yanfang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2860626/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Gastroenterology, Affiliated Hospital of Jiangnan University</institution>, <city>Wuxi</city>,&#xa0;<country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Wuxi School of Medicine, Jiangnan University</institution>, <city>Wuxi</city>,&#xa0;<country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Renjuan Sun, <email xlink:href="mailto:15061885987@163.com">15061885987@163.com</email>; Yanfang Luo, <email xlink:href="mailto:13921538189@163.com">13921538189@163.com</email></corresp>
<fn fn-type="equal" id="fn003">
<label>&#x2020;</label>
<p>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-20">
<day>20</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1751497</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>02</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Lu, Ma, Xia, Zhang, Liu, Yu, Sun and Luo.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Lu, Ma, Xia, Zhang, Liu, Yu, Sun and Luo</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-20">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Flourishing is a key positive psychological construct that has been linked to favorable health-related outcomes in patients with inflammatory bowel disease in prior research. However, current research often overlooks the variations in flourishing levels within this population, as well as the mechanisms through which flourishing interacts with disease progression.</p>
</sec>
<sec>
<title>Objective</title>
<p>This study aimed to identify latent categories of flourishing among patients with inflammatory bowel disease and to analyze the potential influencing factors.</p>
</sec>
<sec>
<title>Methods</title>
<p>This study employed a cross-sectional, descriptive exploratory design involving 316 patients diagnosed with inflammatory bowel disease. Data collection was carried out using a general information questionnaire, the Flourishing Scale (FS), the IBD Self-Efficacy Scale (IBD-SES), the Resilience Scale for Inflammatory Bowel Disease (RS-IBD), and the Social Support Rating Scale (SSRS). Latent profile analysis (LPA) was utilized to identify potential subgroups exhibiting flourishing, while multiple logistic regression analysis was conducted to evaluate the influencing factors.</p>
</sec>
<sec>
<title>Results</title>
<p>The flourishing of individuals with inflammatory bowel disease was classified into three latent groups: the low flourishing-low support beneficiary group (<italic>n</italic> = 66, 20.9%), the moderate flourishing-optimism weakening group (<italic>n</italic> = 182, 57.6%), and the high flourishing-social dignity achievement group (<italic>n</italic> = 68, 21.5%). A multiple logistic regression analysis indicated that marital status, monthly household income, duration of diagnosis, managing stress and emotions, managing symptoms and disease, maintaining remission, and emotional regulation were significant predictors of the latent categories of flourishing among the participants (all <italic>p</italic> &lt; 0.05).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Patients with inflammatory bowel disease demonstrate three distinct latent categories of flourishing. Healthcare professionals should implement more accurate and targeted intervention measures based on the characteristics and influencing factors of different potential categories, in order to improve the flourishing levels of patients with inflammatory bowel disease.</p>
</sec>
</abstract>
<kwd-group>
<kwd>flourishing</kwd>
<kwd>inflammatory bowel disease</kwd>
<kwd>latent profile analysis</kwd>
<kwd>nursing</kwd>
<kwd>psychological resilience</kwd>
<kwd>social support</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Wuxi Nursing Association 2025 Youth Project for Nursing Research (Grant No. Q202504), the &#x201c;Seedling Cultivation&#x201d; Project of Nursing Science Research at Jiangnan University Affiliated Hospital (Grant No. HL-25-Z02), the Soft Science Topic of the Wuxi Association for Science and Technology (Grant No. KX-25-C082), and the Jiangsu Hospital Association Hospital Management Innovation Research Project (Grant No. JSYGY-3-2025-494).</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="71"/>
<page-count count="15"/>
<word-count count="9794"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Public Mental Health</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Inflammatory bowel disease (IBD) is an immune-mediated gastrointestinal disorder that includes Crohn&#x2019;s disease (CD) and ulcerative colitis (UC). It is characterized by chronic, recurrent intestinal inflammation, a prolonged course with frequent relapses, and presents significant challenges in achieving a cure. Currently, there is no definitive cure for this condition (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). The global incidence of IBD has been increasing, with China&#x2019;s rate rising from 1.45 per 100,000 people in 1990 to 3.62, resulting in an estimated cumulative total of approximately 911,000 cases (<xref ref-type="bibr" rid="B3">3</xref>). In addition to intestinal symptoms, IBD imposes a considerable public health burden. Patients frequently experience extra-intestinal manifestations such as joint degeneration and osteoporosis, and many suffer from mental health issues (<xref ref-type="bibr" rid="B4">4</xref>). Research indicates that over 32.1% of IBD patients experience anxiety, 25.2% suffer from depression, and numerous individuals endure stigma, loneliness, and fear of recurrence associated with the disease (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). These psychological challenges not only significantly impair a patients&#x2019; health-related quality of life and functional status, but also affect disease prognosis and escalate medical costs. This underscores the urgent need to explore comprehensive disease management strategies (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Traditionally, the management of IBD has focused mainly on drug treatment and alleviation of intestinal symptoms. However, patients, doctors, and families often overlook the crucial role of mental health support in treatment and rehabilitation (<xref ref-type="bibr" rid="B9">9</xref>). Increasing evidence suggests that psychological intervention is of significant value, capable of reducing pain, alleviating negative emotions, and positively regulating patients&#x2019; mental health (<xref ref-type="bibr" rid="B10">10</xref>). For instance, higher psychological resilience is independently associated with lower anxiety levels in IBD patients, with each additional point in resilience score reducing anxiety severity (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Meanwhile, higher perceived stress significantly increases the risk of clinical relapse (<xref ref-type="bibr" rid="B13">13</xref>). These findings collectively suggest that flourishing, a core concept within the framework of positive psychology, may represent a significant focus for understanding the psychological adaptation of patients with IBD. Broadly, flourishing is associated with positive outcomes for individuals with chronic diseases, including reduced self-reported negative emotions, enhanced subjective well-being, and improved self-management behaviors, all of which contribute to an overall enhancement in quality of life. It is important to explicitly note that the operationalization of flourishing in the present study is somewhat limited. We employed a self-assessment scale comprising eight items to evaluate participants&#x2019; subjective perception of flourishing, rather than conducting a comprehensive assessment of psychological functions and behaviors.</p>
<p>Flourishing is a comprehensive mental health state rooted in positive psychology theory, integrating emotional, psychological and social dimensions of health performance. It serves as an emerging, holistic and structured indicator for assessing subjective well-being (<xref ref-type="bibr" rid="B14">14</xref>). The founder of positive psychology, Martin Seligman, proposed in 2011 that the central theme of positive psychology is happiness, with its ultimate goal being the enhancement of individuals&#x2019; flourishing levels (<xref ref-type="bibr" rid="B15">15</xref>). Unlike previous mental health research (<xref ref-type="bibr" rid="B16">16</xref>)that primarily focused on minimizing negative emotions, positive psychology emphasizes the exploration of individual positive emotional experiences, thereby facilitating the development of positive psychological qualities and behavioral models. Studies have indicated that promoting flourishing is a key objective in the treatment of chronic diseases (<xref ref-type="bibr" rid="B17">17</xref>). For patients with IBD, clinically, flourishing can serve as an active psychological resource. It buffers the stress response pathway by promoting adaptive strategies such as problem-solving and seeking social support, thereby potentially alleviating the psychological burden caused by chronic inflammation and recurrence of disease symptoms (<xref ref-type="bibr" rid="B18">18</xref>). Moreover, patients with IBD who have a higher level of flourishing are more likely to view the disease as a controllable challenge, have a lower perception of the disease&#x2019;s impact, and thus reduce its interference with daily functioning, social participation, and self-identity (<xref ref-type="bibr" rid="B19">19</xref>). At the same time, flourishing integrates core dimensions such as emotional health, sense of meaning in life, and social connection, which can partially counteract fatigue related to IBD, social isolation, and treatment uncertainty, and become an important protective factor for HRQoL (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>In conclusion, despite the theoretical potential of flourishing, current research in this area exhibits significant deficiencies. The flourishing theory posits that the formation and maintenance of a flourishing state are driven by both an individual&#x2019;s internal psychological resources and the external social environment. The former emphasizes positive psychological assets such as self-efficacy and psychological resilience, while the latter highlights nurturing factors from the environment, including social support. (<xref ref-type="bibr" rid="B21">21</xref>) However, existing studies have notable gaps in addressing this theoretical framework in the context of patients with IBD: on one hand, there is a lack of empirical data regarding the flourishing status of patients with IBD; on the other hand, existing studies have not adequately considered the differences in flourishing levels among patient groups, nor have they not fully elucidated the disparities in flourishing among patients with varying characteristics. Furthermore, self-efficacy, psychological resilience and social support, as key psychological and social factors influencing flourishing, have not been adequately incorporated into the analysis of the diversity of flourishing among patients with IBD.</p>
<p>Self-efficacy, a concept proposed by Bandura (<xref ref-type="bibr" rid="B22">22</xref>), refers to an individual&#x2019;s belief in their ability to perform specific behaviors to achieve desired outcomes. This concept has been extensively applied in the health domain and is regarded as a positive psychological factor that may protect patients with IBD as they cope with and manage various challenges (<xref ref-type="bibr" rid="B23">23</xref>). The chronic and recurrent nature of gastrointestinal inflammation coupled with fluctuating symptoms during active phases of the disease, significantly impacts IBD patients&#x2019; perceptions of disease severity and stress levels, consequently increasing their psychological distress. Existing studies have confirmed that the prevalence of mental health comorbidities among IBD patients is significantly higher than that in the general population, with estimates suggesting rates that are approximately two to three times greater (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Moreover, research indicates that high self-efficacy among patients is closely associated with improved emotional regulation, reduced stress levels, and greater utilization of adaptive coping strategies (<xref ref-type="bibr" rid="B26">26</xref>). For IBD patients, the unpredictability of disease progression and the potential for social stigmatization of symptoms&#xa0;underscore the critical role of self-efficacy in effective disease&#xa0;management. Nonetheless, the relationship between self-efficacy&#xa0;and flourishing remains ambiguous and warrants further investigation.</p>
<p>Psychological resilience is a positive psychological trait that refers to an individual&#x2019;s ability to protect or recover from adversity, threats, or significant pressures. This trait facilitates the restoration of normal physiological and psychological functions (<xref ref-type="bibr" rid="B27">27</xref>). Relevant studies indicate that individuals with high psychological resilience are more adept at integrating their positive psychological qualities with external support resources. By actively adapting to challenging situations and engaging in diverse health-promoting behaviors to address disease-related challenges, these individuals can effectively enhance and sustain their subjective well-being as well as their physical and mental health (<xref ref-type="bibr" rid="B28">28</xref>). It is important to note that the chronic persistence, symptom recurrence, and social stigmatization characteristics of IBD (<xref ref-type="bibr" rid="B29">29</xref>) make patients susceptible to developing post-traumatic stress disorder and predispose them to gastrointestinal stress sensitivity (<xref ref-type="bibr" rid="B30">30</xref>). This characteristic underscores the vital role of psychological resilience in mitigating disease-related stress and improving emotional health, while also serving as a significant factor influencing the flourishing of patients.</p>
<p>Social support refers to the perceived or actual assistance individuals receive from social interactions (<xref ref-type="bibr" rid="B31">31</xref>), and is primarily categorized into objective support, subjective support, and the degree of utilization of support. Living with IBD can be a stressful experience for patients. According to stress and coping theory, social support serves as an external resource that mitigates stress (<xref ref-type="bibr" rid="B32">32</xref>). As a protective resource, it alleviates emotional distress and empowers patients to actively manage their condition, thereby influencing their overall physical and mental well-being. Consequently, examining the impact of varying levels of social support on the flourishing of IBD patients can provide valuable insights into their needs and inform the development of targeted intervention strategies.</p>
<p>Previous studies have demonstrated that socio-demographic factors (such as marital status and economic burden) and disease-related factors (including disease duration, disease activity, and complications) are closely associated with the psychological outcomes of patients with IBD. Specifically, marital status may serve a buffering role; unmarried patients are more likely to experience negative psychological states due to a limited support network when confronted with the long-term uncertainties of their condition (<xref ref-type="bibr" rid="B33">33</xref>). Additionally, patients with low family income or those responsible for their own medical expenses often face a higher economic burden, which can increase their susceptibility to anxiety and emotional distress, thereby adversely affecting their mental health (<xref ref-type="bibr" rid="B34">34</xref>). Furthermore, patients diagnosed for less than one year and experiencing active disease must navigate both the uncertainty of prognosis and the pressures of role adaptation, which may hinder the development of a positive psychological state (<xref ref-type="bibr" rid="B35">35</xref>). The study also indicates that patients with IBD-related complications may endure greater physical and psychological pain, leading to a heavier emotional burden that is detrimental to the formation of a positive psychological state (<xref ref-type="bibr" rid="B36">36</xref>). Consequently, this study simultaneously examines these demographic and disease-related variables to identify the key factors influencing the psychological profile of IBD patients.</p>
<p>Latent Profile Analysis (LPA) is a person-centered approach that categorizes individuals into subgroups based on intricate patterns of variables, thereby facilitating the identification of potential heterogeneity in the literature (<xref ref-type="bibr" rid="B37">37</xref>). It has been extensively utilized in psychological research, including the examination of subtypes of psychological adaptation patterns (<xref ref-type="bibr" rid="B36">36</xref>), and the classification of disease burden subtypes in IBD patients (<xref ref-type="bibr" rid="B34">34</xref>). Therefore, this study focuses on IBD patients and employs latent profile analysis (LPA) to explore the heterogeneity of their flourishing. The primary objective is to identify the sociodemographic and clinical characteristics associated with these features and to analyze their relationship with self-efficacy, psychological resilience and social support. The research findings will provide a theoretical foundation for healthcare professionals to design targeted psychological support strategies, optimize disease management based on psychological factors, and develop personalized mental health plans. Ultimately, these efforts will enhance psychological rehabilitation outcomes and improve the quality of life for patients with IBD.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Sampling and inclusion criteria</title>
<p>This cross-sectional exploratory survey was conducted at a tertiary hospital in Wuxi, China, involving a total of 316 individuals diagnosed with IBD between April and August 2025.</p>
<p>The inclusion criteria for participants were as follows: (1) aged 18 years or older, (2) met the diagnostic criteria for IBD (<xref ref-type="bibr" rid="B38">38</xref>), (3) demonstrated the ability to accurately read and comprehend the questionnaire without communication barriers, and (4) provided informed consent voluntarily. The exclusion criteria included: (1) a disease duration of less than three months, (2) life-threatening conditions confirmed by the attending physician via the electronic medical record include: severe organ failure and advanced malignant tumors. (3) additionally, severe mental or cognitive disorders are identified according to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition), characterized by a score of &#x2264; 23 on the Mini-Mental State Examination Scale and a score of &gt; 11 on the Hamilton Anxiety and Depression Scale. (<xref ref-type="bibr" rid="B39">39</xref>). The sample size was estimated based on the rule of thumb for multivariate analyses, which required 5&#x2013;10 observations per independent variable (<xref ref-type="bibr" rid="B40">40</xref>). This study included a total of 27 independent variables; therefore, considering a 10% non-response rate, a minimum of 300 participants was deemed necessary. Meanwhile, with reference to Ferguson et&#xa0;al. (<xref ref-type="bibr" rid="B41">41</xref>), who recommended a minimum sample size of 300 for LPA, we ultimately enrolled 316 IBD patients.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Data collection</title>
<p>Two trained researchers conducted the survey with participants who met the inclusion criteria at the time of enrollment. Prior to administering the survey, the researchers provided a comprehensive explanation of the study&#x2019;s purpose and obtained written informed consent from all participants. Patients were instructed to complete the anonymous questionnaire independently. Standardized instructions were provided to ensure clarity, encompassing the content, key points, and responses to potential questions. Fully completed questionnaires were collected for immediate quality control and any missing items were promptly addressed. Disease-related information was obtained from electronic medical records or through direct patient interviews. All questionnaire items were mandatory. Surveys that exhibited consistent response patterns, identical answers across all questions, or completion times of less than five minutes were deemed invalid.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Instruments</title>
<sec id="s2_3_1">
<label>2.3.1</label>
<title>General information questionnaire</title>
<p>This study was designed by the researchers following an extensive literature review and consisted of two primary components. Demographic characteristics were collected using a self-administered questionnaire that included gender, age, employment status, marital status, place of family residence, education level, monthly household income, medical payment methods, and self-perceived financial stress. Disease-related characteristics included type of disease, duration of diagnosis, total number of recurrence occurrences, current disease status, and IBD-related complications.</p>
<p>In the context of ulcerative colitis (UC), disease activity was assessed using the Wallemarius Simplified Clinical Colitis Activity Index (SCCAI), where scores below than 3 indicate remission and scores of 3 or higher indicate active disease (<xref ref-type="bibr" rid="B42">42</xref>). For Crohn&#x2019;s disease (CD), the Harvey-Bradshaw Index (HBI) was utilized, with scores below 5 indicating remission and scores of 5 or above indicating active disease (<xref ref-type="bibr" rid="B43">43</xref>).</p>
</sec>
<sec id="s2_3_2">
<label>2.3.2</label>
<title>Flourishing Scale</title>
<p>The Flourishing Scale (FS), developed by Diener (<xref ref-type="bibr" rid="B44">44</xref>) and localized into Chinese by Lai Qiaozhen (<xref ref-type="bibr" rid="B45">45</xref>), comprises eight items: meaning, self-acceptance, interpersonal relationships, helping others, engagement, self-competence, optimism about the future, and respect from others. Each item is assessed on a 7-point Likert scale, which ranges from 1 (&#x201c;strongly disagree&#x201d;) to 7 (&#x201c;strongly agree&#x201d;). Higher scores reflect greater levels of flourishing. In this study, the Cronbach&#x2019;s &#x3b1; coefficient of this scale was 0.92.</p>
</sec>
<sec id="s2_3_3">
<label>2.3.3</label>
<title>The Inflammatory Bowel Disease Self-efficacy Scale</title>
<p>The Inflammatory Bowel Disease Self-efficacy Scale (IBD-SES), developed by Keefer (<xref ref-type="bibr" rid="B46">46</xref>). and localized into Chinese by Tu Wenjing (<xref ref-type="bibr" rid="B47">47</xref>), was utilized to assess patients&#x2019; confidence in managing their IBD. This scale comprises 29 items, categorized into four dimensions: managing stress and emotions (9 items), managing medical care (8 items), managing symptoms and disease (7 items), and maintaining remission (5 items). Each item is rated on a 10-point Likert scale, ranging from 1 (&#x201c;no confidence at all&#x201d;) to 10 (&#x201c;absolute confidence&#x201d;). The total score varies from 29 to 290, with higher scores indicating greater self-efficacy in managing IBD. In this study, the Cronbach&#x2019;s &#x3b1; coefficients for each dimension of the scale ranged from 0.741 to 0.970, the Cronbach&#x2019;s alpha coefficient for the IBD-SES was 0.83, suggesting good reliability.</p>
</sec>
<sec id="s2_3_4">
<label>2.3.4</label>
<title>Resilience Scale for Inflammatory Bowel Disease</title>
<p>The Resilience Scale for Inflammatory Bowel Disease (RS-IBD) was developed by Dan Luo (<xref ref-type="bibr" rid="B48">48</xref>). This questionnaire comprises of 25 items categorized into six dimensions: self-management on disease (four items), active response to difficulty (six items), positive cognition (five items), emotional regulation (four items), family support (three items) and other patients&#x2019; support (three items). A 5-point Likert scale was utilized for scoring, where 0 indicates &#x201c;never&#x201d; and 4 indicates &#x201c;always&#x201d;. The total score ranges from 0 to 100, with higher scores reflecting enhanced mental resilience. In this study, the Cronbach&#x2019;s &#x3b1; coefficients for each dimension of the scale ranged from 0.765 to 0.952, the Cronbach&#x2019;s &#x3b1; coefficient was determined to be 0.89.</p>
</sec>
<sec id="s2_3_5">
<label>2.3.5</label>
<title>Social Support Rating Scale</title>
<p>The Social Support Rating Scale (SSRS), developed by Xiao Shuiyuan (<xref ref-type="bibr" rid="B49">49</xref>), is designed to assess the level of social support received by patients. This scale encompasses three dimensions: subjective support, objective support, and support availability, comprising a total of 10 items. Among these, Items 1&#x2013;4 and 8&#x2013;10 are scored on a scale from 1 to 4; Item 5 offers four options, scored from 1 (&#x201c;no support&#x201d;) to 4 (&#x201c;full support&#x201d;); for items 6 and 7, participants received a score of 0 if no support was listed, while any selected option was counted as 1 point per option. The total score ranges from 12 to 66, with higher total scores indicating a greater level of social support. To verify the applicability of this scale to the current sample, we conducted tests for the lower limit effect and the upper limit effect. We employed the conventional method (<xref ref-type="bibr" rid="B50">50</xref>) for the tests and the results indicated that there were no significant lower limit effects or upper limit effects observed in this study. Additionally, the Cronbach&#x2019;s &#x3b1; coefficients for each dimension of the scale ranged from 0.825 to 0.849, demonstrating good internal consistency.</p>
</sec>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Statistical analysis</title>
<p>Data entry and verification were conducted by two trained personnel to ensure accuracy and consistency. Little&#x2019;s test for completely random missingness indicated a non-significant result (<italic>p</italic> = 0.101), suggesting that data were missing completely at random and were subsequently removed listwise.</p>
<p>Latent profile analysis was conducted using Mplus 8.3, treating the average score of each item in the flourishing scale as a continuous manifest variable. The initial model began with &#x201c;C1&#x201d;, and the number of profiles was incrementally increased until the optimal model fit index was achieved. The fitting indicators for the latent profile analysis model included the Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), sample-adjusted Bayesian Information Criterion (aBIC), information entropy (Entropy), and the likelihood ratio tests: the Lo-Mendell-Rubin corrected likelihood ratio test (LMRT) and the Bootstrap-based likelihood ratio test (BLRT). Among these, lower values of AIC, BIC, and aBIC indicate a better model fit. An entropy value of &#x2265; 0.8 signifies that the classification accuracy exceeds 90%, with values closer to 1 indicating greater accuracy. The P values for LMRT and BLRT reaching a significant level suggest that the model with k categories is significantly superior to the model with k-1 categories. Through a comprehensive evaluation of the model fit indices and practical interpretability, the optimal latent profile model was identified.</p>
<p>Data analysis was conducted with SPSS 27.0 software. Given that this study primarily relied on patients&#x2019; self-reports, which may introduce common method bias, the Harman single-factor method and the unmeasured latent method factor analysis (ULMC) were employed to assess such biases within the scale items. (<xref ref-type="bibr" rid="B51">51</xref>). A variance contribution rate of less than 40% for the first factor indicated that common method bias was not severe. Continuous data that adhered to a normal distribution were reported as mean &#xb1; standard deviation. The study sample consisted of 316 participants, which is adequate since a sample size of at least 50 is deemed appropriate for the Kolmogorov-Smirnov test for normality (<xref ref-type="bibr" rid="B52">52</xref>). Meanwhile, the homoscedasticity test was conducted using the Levene test. Comparisons among multiple groups were performed using one-way analysis of variance, while count data were expressed as frequencies, percentages, or proportions. For unordered categorical variables, the chi-square test or Fisher&#x2019;s exact test was utilized for comparisons; for ordered categorical variables, the Kruskal-Wallis H test was applied a variance inflation factor (VIF) of 5 or greater indicated a high degree of multicollinearity (<xref ref-type="bibr" rid="B53">53</xref>). <italic>Post-hoc</italic> tests were conducted using Bonferroni method for categorical variables and Scheffe&#x2019;s test for continuous variables. Following the removal of problematic variables, a logistic regression analysis was conducted. Multivariate logistic regression was employed to identify the influencing factors affecting patients&#x2019; flourishing in IBD. A <italic>p</italic>-value of less than 0.05 was considered statistically significant.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Validity and reliability</title>
<p>The study adhered to the STROBE guidelines for reporting observational studies. All participants provided written informed consent in accordance with ethical research requirements. The methods and procedures were designed to comply with established standards for human research and were conducted in strict adherence to relevant regulations and guidelines.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Participants&#x2019; characteristics</title>
<p>In this study, a total of 342 participants were recruited, and 325 valid questionnaires were retrieved, resulting in an effective recovery rate of 95.03%. Little&#x2019;s MCAR test indicated that the missing data in the 325 valid questionnaires satisfied the assumption of completely missing at random (MCAR). Statistically, the individual-level missing rate was 2.8% (9 cases out of 325), which is below the 5% threshold. Given that the data met the MCAR assumption and the missing rate was low, this study employed the listwise deletion method for handling the missing data (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>), which involved removing the 9 individuals with any missing variables. Consequently, a complete dataset of 316 patients was included for statistical analysis (<xref ref-type="bibr" rid="B56">56</xref>). (STROBE flow diagram as shown in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;1</bold></xref>).</p>
<p>Regarding the demographic characteristics, among the 316 patients with IBD in this study, 63.0% were male and 37.0% were female. The higher proportion of males compared to females aligns with the epidemiological characteristics of IBD in China. According to the Global Burden of Disease Study data from 2019, there is a slight male predominance among Chinese IBD patients, which may be attributed to higher smoking rates among men and differences in hormone levels. In terms of age distribution, the 18&#x2013;45 age group comprised 56.0%, which is consistent with the core epidemiological characteristics of IBD in young adults. Regarding social roles, 66.8% of the patients were employed, and 80.7% were married. This distribution aligns with the clinical characteristics of IBD patients, who often find themselves in critical periods of both family responsibilities and career development. In terms of clinical features, among the 316 IBD patients, 57.0% had UC and 43.0% had CD. Although the proportion of UC remains higher than that of CD, the two proportions have become closer. The distribution of disease duration predominantly reflects short to medium-term disease courses, with 60.1% having a duration of 1 to less than 5 years. This distribution is related to the rapid increase in the incidence of IBD in China. In terms of disease status, 72.2% of the patients were in a remission period, and 59.2% had no IBD-related complications, which corresponds with the natural course of intermittent attacks and long-term remission typical of chronic inflammatory diseases. Regarding economic burden, 63.0% of the patients experienced moderate economic pressure, while 15.2% faced high economic pressure. This result aligns with the findings regarding the economic burden experienced by patients with IBD and the implementation of medical insurance policies in China. Although infliximab and other biological agents have been included in the 2020 National Medical Insurance Catalogue, the ongoing need for long-term medication and repeated examinations continues to impose significant economic pressure on patients. This situation establishes a crucial clinical foundation for the subsequent analysis of how economic factors affect patients&#x2019; psychological states. General information about the 316 IBD patients is summarized in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Demographic and clinical characteristics of the participants.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Characteristics</th>
<th valign="middle" rowspan="2" align="center">Total (<italic>n</italic> = 316)</th>
<th valign="middle" colspan="3" align="center">Classification of latent classes</th>
<th valign="middle" rowspan="2" align="center"><italic>&#x3c7;<sup>2</sup>/H/F</italic></th>
<th valign="middle" rowspan="2" align="center"><italic>P</italic></th>
</tr>
<tr>
<th valign="middle" align="center">Class 1 (<italic>n</italic> = 66)</th>
<th valign="middle" align="center">Class 2 (<italic>n</italic> = 182)</th>
<th valign="middle" align="center">Class 3 (<italic>n</italic> = 68)</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="middle" align="left">Gender</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">1.186 <sup>a</sup></th>
<th valign="middle" align="left">0.553</th>
</tr>
<tr>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">199(63.0)</td>
<td valign="middle" align="left">44(66.7)</td>
<td valign="middle" align="left">110(60.4)</td>
<td valign="middle" align="left">45(66.2)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">117(37.0)</td>
<td valign="middle" align="left">22(33.3)</td>
<td valign="middle" align="left">72(39.6)</td>
<td valign="middle" align="left">23(33.8)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Age (years)</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">0.345 <sup>b</sup></th>
<th valign="middle" align="left">0.842</th>
</tr>
<tr>
<td valign="middle" align="left">18-&lt;45</td>
<td valign="middle" align="left">177(56.0)</td>
<td valign="middle" align="left">35(53.0)</td>
<td valign="middle" align="left">105(57.7)</td>
<td valign="middle" align="left">37(54.4)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">45-&lt;60</td>
<td valign="middle" align="left">62(19.6)</td>
<td valign="middle" align="left">14(21.2)</td>
<td valign="middle" align="left">33(18.1)</td>
<td valign="middle" align="left">15(22.1)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">&#x2265;60</td>
<td valign="middle" align="left">77(24.4)</td>
<td valign="middle" align="left">17(25.8)</td>
<td valign="middle" align="left">44(24.2)</td>
<td valign="middle" align="left">16(23.5)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Employment status</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">1.408 <sup>a</sup></th>
<th valign="middle" align="left">0.847</th>
</tr>
<tr>
<td valign="middle" align="left">Employment</td>
<td valign="middle" align="left">211(66.8)</td>
<td valign="middle" align="left">41(62.1)</td>
<td valign="middle" align="left">125(68.7)</td>
<td valign="middle" align="left">455(66.2)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Unemployment</td>
<td valign="middle" align="left">58(18.3)</td>
<td valign="middle" align="left">14(21.2)</td>
<td valign="middle" align="left">30(16.5)</td>
<td valign="middle" align="left">14(20.6)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Student</td>
<td valign="middle" align="left">47(14.9)</td>
<td valign="middle" align="left">11(16.7)</td>
<td valign="middle" align="left">27(14.8)</td>
<td valign="middle" align="left">9(13.2)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Marital status</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">13.861&#xa0;<sup>a</sup></th>
<th valign="middle" align="left">&lt;0.001</th>
</tr>
<tr>
<td valign="middle" align="left">Married</td>
<td valign="middle" align="left">255(80.7)</td>
<td valign="middle" align="left">43(65.2)</td>
<td valign="middle" align="left">157(86.3) <sup>d</sup></td>
<td valign="middle" align="left">55(80.9)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Unmarried or divorced or widowed</td>
<td valign="middle" align="left">61(19.3)</td>
<td valign="middle" align="left">23(34.8)</td>
<td valign="middle" align="left">25(13.7) <sup>d</sup></td>
<td valign="middle" align="left">13(19.1)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Place of family residence</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">5.486 <sup>a</sup></th>
<th valign="middle" align="left">0.064</th>
</tr>
<tr>
<td valign="middle" align="left">A city or town</td>
<td valign="middle" align="left">266(84.2)</td>
<td valign="middle" align="left">57(86.4)</td>
<td valign="middle" align="left">158(86.8)</td>
<td valign="middle" align="left">51(75.0)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Rural area</td>
<td valign="middle" align="left">50(15.8)</td>
<td valign="middle" align="left">9(13.6)</td>
<td valign="middle" align="left">24(13.2)</td>
<td valign="middle" align="left">17(25.0)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Education level</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">0.316 <sup>b</sup></th>
<th valign="middle" align="left">0.854</th>
</tr>
<tr>
<td valign="middle" align="left">Primary school and below</td>
<td valign="middle" align="left">45(14.2)</td>
<td valign="middle" align="left">9(13.6)</td>
<td valign="middle" align="left">24(13.2)</td>
<td valign="middle" align="left">12(17.6)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Junior/technical secondary/high school</td>
<td valign="middle" align="left">109(34.5)</td>
<td valign="middle" align="left">24(36.4)</td>
<td valign="middle" align="left">63(34.6)</td>
<td valign="middle" align="left">22(32.4)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Associate degree or above</td>
<td valign="middle" align="left">162(51.3)</td>
<td valign="middle" align="left">33(50.0)</td>
<td valign="middle" align="left">95(52.2)</td>
<td valign="middle" align="left">34(50.0)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Monthly household income (yuan)</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">7.744 <sup>b</sup></th>
<th valign="middle" align="left">0.021</th>
</tr>
<tr>
<td valign="middle" align="left">&lt;3000</td>
<td valign="middle" align="left">46(14.6)</td>
<td valign="middle" align="left">18(27.3)</td>
<td valign="middle" align="left">22(12.1) <sup>d</sup></td>
<td valign="middle" align="left">6(8.8) <sup>d</sup></td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">3000-&lt;5000</td>
<td valign="middle" align="left">204(64.5)</td>
<td valign="middle" align="left">37(56.1)</td>
<td valign="middle" align="left">123(67.6)</td>
<td valign="middle" align="left">44(64.7)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">&#x2265;5000</td>
<td valign="middle" align="left">66(20.9)</td>
<td valign="middle" align="left">11(16.7)</td>
<td valign="middle" align="left">37(20.3)</td>
<td valign="middle" align="left">18(26.5)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Medical payment methods</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">3.078 <sup>c</sup></th>
<th valign="middle" align="left">0.517</th>
</tr>
<tr>
<td valign="middle" align="left">The medical insurance for urban residents</td>
<td valign="middle" align="left">265(83.9)</td>
<td valign="middle" align="left">58(87.9)</td>
<td valign="middle" align="left">154(84.6)</td>
<td valign="middle" align="left">53(77.9)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Rural cooperative medical service</td>
<td valign="middle" align="left">46(14.6)</td>
<td valign="middle" align="left">7(10.6)</td>
<td valign="middle" align="left">25(13.7)</td>
<td valign="middle" align="left">14(20.6)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Others (at own or public expense)</td>
<td valign="middle" align="left">5(1.5)</td>
<td valign="middle" align="left">1(1.5)</td>
<td valign="middle" align="left">3(1.7)</td>
<td valign="middle" align="left">1(1.5)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Type of disease</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">1.023 <sup>a</sup></th>
<th valign="middle" align="left">0.610</th>
</tr>
<tr>
<td valign="middle" align="left">UC</td>
<td valign="middle" align="left">180(57.0)</td>
<td valign="middle" align="left">41(62.1)</td>
<td valign="middle" align="left">100(54.9)</td>
<td valign="middle" align="left">39(57.4)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">CD</td>
<td valign="middle" align="left">136(43.0)</td>
<td valign="middle" align="left">25(37.9)</td>
<td valign="middle" align="left">82(45.1)</td>
<td valign="middle" align="left">29(42.6)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Duration of diagnosis (years)</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">22.624&#xa0;<sup>b</sup></th>
<th valign="middle" align="left">&lt;0.001</th>
</tr>
<tr>
<td valign="middle" align="left">&lt;1</td>
<td valign="middle" align="left">28(8.9)</td>
<td valign="middle" align="left">17(25.8)</td>
<td valign="middle" align="left">7(3.8) <sup>d</sup></td>
<td valign="middle" align="left">4(5.9) <sup>d</sup></td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">1-&lt;5</td>
<td valign="middle" align="left">190(60.1)</td>
<td valign="middle" align="left">39(59.1)</td>
<td valign="middle" align="left">112(61.6)</td>
<td valign="middle" align="left">39(57.3)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">&#x2265;5</td>
<td valign="middle" align="left">98(31.0)</td>
<td valign="middle" align="left">10(15.1)</td>
<td valign="middle" align="left">63(34.6) <sup>d</sup></td>
<td valign="middle" align="left">25(36.8) <sup>d</sup></td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Total number of recurrence occurrences(times)</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">2.340 <sup>b</sup></th>
<th valign="middle" align="left">0.310</th>
</tr>
<tr>
<td valign="middle" align="left">&lt;5</td>
<td valign="middle" align="left">26(8.2)</td>
<td valign="middle" align="left">5(7.6)</td>
<td valign="middle" align="left">13(7.1)</td>
<td valign="middle" align="left">8(11.8)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">5-10</td>
<td valign="middle" align="left">249(78.8)</td>
<td valign="middle" align="left">49(74.2)</td>
<td valign="middle" align="left">147(80.8)</td>
<td valign="middle" align="left">53(77.9)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">&gt;10</td>
<td valign="middle" align="left">41(13.0)</td>
<td valign="middle" align="left">12(18.2)</td>
<td valign="middle" align="left">22(12.1)</td>
<td valign="middle" align="left">7(10.3)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Current disease status</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">12.713 <sup>b</sup></th>
<th valign="middle" align="left">0.002</th>
</tr>
<tr>
<td valign="middle" align="left">Remission stage</td>
<td valign="middle" align="left">228(72.2)</td>
<td valign="middle" align="left">39(59.1)</td>
<td valign="middle" align="left">144(79.1) <sup>d</sup></td>
<td valign="middle" align="left">45(66.2)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Mild active stage</td>
<td valign="middle" align="left">62(19.6)</td>
<td valign="middle" align="left">16(24.2)</td>
<td valign="middle" align="left">30(16.5)</td>
<td valign="middle" align="left">16(23.5)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Moderate to severe active stage</td>
<td valign="middle" align="left">26(8.2)</td>
<td valign="middle" align="left">11(16.7)</td>
<td valign="middle" align="left">8(4.4) <sup>d</sup></td>
<td valign="middle" align="left">7(10.3)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">IBD-related complications*</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">7.406 <sup>a</sup></th>
<th valign="middle" align="left">0.025</th>
</tr>
<tr>
<td valign="middle" align="left">No</td>
<td valign="middle" align="left">187(59.2)</td>
<td valign="middle" align="left">36(54.5)</td>
<td valign="middle" align="left">101(55.5)</td>
<td valign="middle" align="left">50(73.5) <sup>e</sup></td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">129(40.8)</td>
<td valign="middle" align="left">30(45.5)</td>
<td valign="middle" align="left">81(44.5)</td>
<td valign="middle" align="left">18(26.5) <sup>e</sup></td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" align="left">Self-perceived financial stress</th>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left"/>
<th valign="middle" align="left">4.976 <sup>b</sup></th>
<th valign="middle" align="left">0.083</th>
</tr>
<tr>
<td valign="middle" align="left">No stress</td>
<td valign="middle" align="left">69(21.8)</td>
<td valign="middle" align="left">12(18.2)</td>
<td valign="middle" align="left">39(21.4)</td>
<td valign="middle" align="left">18(26.5)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">Moderate stress</td>
<td valign="middle" align="left">199(63.0)</td>
<td valign="middle" align="left">38(57.6)</td>
<td valign="middle" align="left">117(64.3)</td>
<td valign="middle" align="left">44(64.7)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">High stress</td>
<td valign="middle" align="left">48(15.2)</td>
<td valign="middle" align="left">16(24.2)</td>
<td valign="middle" align="left">26(14.3)</td>
<td valign="middle" align="left">6(8.8)</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Data are n (%). Class 1 = low flourishing group, Class 2 = moderate flourishing group, Class 3 = high flourishing group. UC, ulcerative colitis; CD, Crohn disease. *Complications refer to the occurrence of one or more conditions such as gastrointestinal bleeding, intestinal perforation, and intestinal obstruction.</p></fn>
<fn>
<p><sup>a</sup> &#x3c7;<sup>2</sup> value; <sup>b</sup> Kruskal - Wallis <italic>H</italic> value; <sup>c</sup> Fisher&#x2019;s exact test.</p></fn>
<fn>
<p><sup>d</sup> Compared with Class 1, <italic>P &lt;</italic> 0.05. <sup>e</sup> Compared with Class 2, <italic>P</italic>&#x2009;&lt; 0.05.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Tests for common method bias and multicollinearity</title>
<p>The Harman single-factor test identified 29 factors with eigenvalues exceeding 1, with the first factor contributing 15.5% to the variance. This value is below the 40% threshold, indicating the absence of significant common method bias. Furthermore, this study utilized the ULMC to further assess common method bias. The results revealed that the fit indices for the four-factor measurement model were as follows: CFI = 0.821, TLI = 0.809, SRMR = 0.067, and RMSEA = 0.063. After introducing the method factor, the fit indices for the ULMC model improved to CFI = 0.889, TLI = 0.877, SRMR = 0.054, and RMSEA = 0.051. According to the ULMC method&#x2019;s judgment criteria: where an increase in CFI and TLI should not exceed 0.1, and a decrease in RMSEA and SRMR should not exceed 0.05 the variations in the fit indices for this study remained below the critical thresholds, indicating that severe common method bias is absent. (<xref ref-type="bibr" rid="B55">55</xref>) In the univariate analysis, 14 variables were identified as statistically significant. A multicollinearity test was conducted on these variables, revealing that the tolerance levels (0.581 - 0.996) for each model ere below 1, and the VIF ranged from 1.004 to 1.720, confirming the absence of multicollinearity among these variables and thereby enhancing the overall robustness of the analysis model.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Potential profiles analysis results for IBD patients</title>
<p>LPA was conducted using Mplus 8.3, utilizing the mean scores of each item in the Flourishing Scale as manifest variables. Models with one to four potential latent classes were fitted, and the fitting results are presented in <xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>. As the number of latent classes increased, the AIC, BIC, and aBIC exhibited a gradual decrease, while the Entropy values consistently exceeded 0.80 across all models. The three-class model yielded the highest Entropy value (0.921), indicating superior classification accuracy and reduced uncertainty in individual class membership. Results from the LMRT and BLRT demonstrated that the two-class model significantly outperformed the one-class model, and the three-class model significantly outperformed the two-class model. Although the BLRT remained significant for the four-class model, the LMRT did not achieve statistical significance, suggesting that the improvement in model fit from the three-class to the four-class model was not substantial. Furthermore, while the AIC, BIC, and aBIC values of the four-class model were slightly lower than those of the three-class model, the reduction was minimal (approximately 1%). Combined with the non-significant LMRT result, this indicates that the substantive value of the improved fit is limited. Comprehensive comparisons revealed that despite the significant BLRT result for the four-class model, it exhibited non-significant LMRT, a minimal decrease (approximately 1%) in information criteria, and a reduced Entropy value. This suggests that adding a fourth class did not yield substantial improvements in model fit or explanatory value. In contrast, the three-class model demonstrated significant statistical fit, reasonable class distribution, and high classification accuracy. Furthermore, the probabilities of IBD patients being assigned to their respective latent classes were 0.967, 0.969, and 0.974, respectively. Therefore, the three-class model was ultimately selected as the optimal model.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Latent class model fit comparison.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="center">Model</th>
<th valign="middle" rowspan="2" align="center"><italic>AIC</italic></th>
<th valign="middle" rowspan="2" align="center"><italic>BIC</italic></th>
<th valign="middle" rowspan="2" align="center"><italic>aBIC</italic></th>
<th valign="middle" rowspan="2" align="center"><italic>Entropy</italic></th>
<th valign="middle" colspan="2" align="center"><italic>P-</italic>value</th>
<th valign="middle" rowspan="2" align="center">Probability of class</th>
</tr>
<tr>
<th valign="middle" align="center"><italic>LMR</italic></th>
<th valign="middle" align="center"><italic>BLRT</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">7413.477</td>
<td valign="middle" align="center">7473.569</td>
<td valign="middle" align="center">7422.821</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">6681.763</td>
<td valign="middle" align="center">6775.657</td>
<td valign="middle" align="center">6696.363</td>
<td valign="middle" align="center">0.898</td>
<td valign="middle" align="center">0.003</td>
<td valign="middle" align="center">&lt;0.001</td>
<td valign="middle" align="center">0.323/0.677</td>
</tr>
<tr>
<td valign="middle" align="center">3</td>
<td valign="middle" align="center">6275.805</td>
<td valign="middle" align="center">6403.500</td>
<td valign="middle" align="center">6295.661</td>
<td valign="middle" align="center">0.921</td>
<td valign="middle" align="center">&lt;0.001</td>
<td valign="middle" align="center">&lt;0.001</td>
<td valign="middle" align="center">0.209/0.576/0.215</td>
</tr>
<tr>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">6206.260</td>
<td valign="middle" align="center">6367.765</td>
<td valign="middle" align="center">6231.380</td>
<td valign="middle" align="center">0.849</td>
<td valign="middle" align="center">0.116</td>
<td valign="middle" align="center">&lt;0.001</td>
<td valign="middle" align="center">0.196/0.301/0.339/0.164</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion; aBIC, adjusted Bayesian Information Criterion; LMR (P), P value for the Lo-Mendell-Rubin; BLRT (P), P value for the Bootstrapped Likelihood Ratio Test.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The flourishing characteristics of patients with IBD are illustrated in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>. Classes 1, 2, and 3 are categorized based on their flourishing scale score distributions. Class 1 (n = 66, 20.9%) exhibited notably low average scores across all flourishing scale items, resulting in a total flourishing scale score of 27.82 &#xb1; 2.24. Between-group comparisons revealed a mean difference (MD) of -6.66 (95% CI [-7.75, -5.57]) when contrasting Class 1 with Class 2, and -12.82 (95% CI [-14.13, -11.50]) when comparing Class 1 with Class 3. The average scores for individual items ranged from 2.04 to 4.11, reflecting an overall low level of flourishing; thus, this class is designated as the &#x201c;Low Flourishing Group.&#x201d; Class 2 (n = 182, 57.6%) demonstrated relatively high average scores for all FS items, culminating in a total flourishing score of 34.34 &#xb1; 3.31. Inter-group comparisons indicated an average difference (MD) of -6.16 (95% CI [-7.24, -5.08]) between Class 2 and Class 3, with individual item scores ranging from 3.13 to 5.62. This suggests a moderately elevated level of flourishing, leading to its classification as the &#x201c;Moderate Flourishing Group.&#x201d; Class 3 (n = 68, 21.5%) exhibited the highest average scores across all FS items, resulting in a total flourishing score of 40.50 &#xb1; 3.49. Individual item scores ranged from 4.38 to 6.34, indicating a favorable state of flourishing; therefore, this class is labeled as the &#x201c;High Flourishing Group.&#x201d;</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Characteristics of three latent profiles of flourishing in patients with IBD. Class 1 = low flourishing group, Class 2 = moderate flourishing group, Class 3 = high flourishing group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-17-1751497-g001.tif">
<alt-text content-type="machine-generated">Line graph showing average scores for eight flourishing scale items across three classes: Class 1 (20.9%) with the lowest scores, Class 2 (57.6%) with intermediate scores, and Class 3 (21.5%) with the highest scores.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_4" sec-type="results">
<label>3.4</label>
<title>Results of univariate analysis of potential subcategories of IBD patients</title>
<p>The results of the univariate analysis demonstrated statistically significant differences among the three patient categories concerning marital status, monthly household income, duration of diagnosis, current disease condition and IBD-related complications (<italic>p</italic> &lt; 0.05), <italic>Post-hoc</italic> multiple comparisons revealed significant differences in monthly household income (less than 3000) and duration of diagnosis (less than 1 year or greater than or equal to 5 years) between the low flourishing group and both the moderate and high flourishing groups. Additionally, the low flourishing group exhibited significant statistical differences from the moderate flourishing group regarding marital status and current disease status. Notably, the differences between the moderate flourishing group and the high flourishing group were significant only in terms of IBD-related complications, as shown in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>. The normality test results, specifically the Kolmogorov-Smirnov test, indicated that the scores of the self-efficacy scale, psychological resilience scale, and social support scale, along with their respective dimensions, followed a normal distribution across the three patient groups. Furthermore, the homogeneity of variance test (Levene test) demonstrated that the p-values for each scale and dimension exceeded 0.05, thus confirming the assumption of homogeneity of variance. Comparisons of the total scores and scores for each dimension of the Chinese version of the self-efficacy scale, the total score of the Chinese version of the resilience scale&#x2014;including its dimensions of family support, positive cognition, and emotion regulation&#x2014;as well as the total score of the social support rating scale and its dimensions of subjective support and support availability revealed statistically significant differences (<italic>p</italic> &lt; 0.05). <italic>Post-hoc</italic> multiple comparisons indicated that the high flourishing group had significantly higher scores in self-efficacy, psychological resilience, and social support compared to the other two groups, as detailed in <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Comparison of the scores of the chinese version of the self-efficacy scale, the psychological resilience scale, and the social support rating scale among patients with inflammatory bowel disease across different latent categories.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Item</th>
<th valign="middle" rowspan="2" align="left">Total&#xa0;scores (<italic>n</italic> = 316)</th>
<th valign="middle" colspan="3" align="center">Classification of latent classes</th>
<th valign="middle" rowspan="2" align="left">Multiple comparisons</th>
<th valign="middle" rowspan="2" align="left"><italic>F</italic>&#xa0;-value</th>
<th valign="middle" rowspan="2" align="left"><italic>P</italic>&#xa0;-value</th>
</tr>
<tr>
<th valign="middle" align="center">Class 1 (<italic>n</italic> = 66)</th>
<th valign="middle" align="center">Class 2 (<italic>n</italic> = 182)</th>
<th valign="middle" align="center">Class 3 (<italic>n</italic> = 68)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Total score of IBD Self-Efficacy Scale</td>
<td valign="middle" align="left">213.5 &#xb1; 15.86</td>
<td valign="middle" align="left">200.02&#xa0;&#xb1;&#xa0;8.28</td>
<td valign="middle" align="left">212.65&#xa0;&#xb1;&#xa0;14.37<sup>f</sup></td>
<td valign="middle" align="left">228.87&#xa0;&#xb1;&#xa0;11.71<sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 2 &gt; Class 1</td>
<td valign="middle" align="left">86.434</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">managing stress and emotions</td>
<td valign="middle" align="left">60.38 &#xb1; 8.58</td>
<td valign="middle" align="left">56.17 &#xb1; 7.11</td>
<td valign="middle" align="left">59.10 &#xb1; 8.07<sup>f</sup></td>
<td valign="middle" align="left">67.87 &#xb1; 6.53<sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 2 &gt; Class 1</td>
<td valign="middle" align="left">46.113</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">managing medical care</td>
<td valign="middle" align="left">68.54 &#xb1; 2.44</td>
<td valign="middle" align="left">68.23 &#xb1; 1.53</td>
<td valign="middle" align="left">68.24 &#xb1; 2.31</td>
<td valign="middle" align="left">69.65 &#xb1; 3.12 <sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 1,<break/>Class 3 &gt; Class 2</td>
<td valign="middle" align="left">9.389</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">managing symptoms and disease</td>
<td valign="middle" align="left">46.46 &#xb1; 5.96</td>
<td valign="middle" align="left">41.50 &#xb1; 2.81</td>
<td valign="middle" align="left">46.64 &#xb1; 5.58<sup>f</sup></td>
<td valign="middle" align="left">50.78 &#xb1; 5.66 <sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 2 &gt; Class 1</td>
<td valign="middle" align="left">54.696</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">maintaining remission</td>
<td valign="middle" align="left">38.13 &#xb1; 4.11</td>
<td valign="middle" align="left">34.12 &#xb1; 2.03</td>
<td valign="middle" align="left">38.66 &#xb1; 3.96<sup>f</sup></td>
<td valign="middle" align="left">40.57 &#xb1; 3.24 <sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 2 &gt; Class 1</td>
<td valign="middle" align="left">62.511</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">Total score of the psychological resilience scale</td>
<td valign="middle" align="left">77.09 &#xb1; 6.26</td>
<td valign="middle" align="left">75.27 &#xb1; 6.71</td>
<td valign="middle" align="left">77.21 &#xb1; 6.16</td>
<td valign="middle" align="left">78.53 &#xb1; 5.68<sup>f</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 1<break/>Class</td>
<td valign="middle" align="left">4.727</td>
<td valign="middle" align="left">0.009</td>
</tr>
<tr>
<td valign="middle" align="left">Family support</td>
<td valign="middle" align="left">10.22 &#xb1; 0.96</td>
<td valign="middle" align="left">9.76 &#xb1; 0.99</td>
<td valign="middle" align="left">10.30 &#xb1; 0.93<sup>f</sup></td>
<td valign="middle" align="left">10.46 &#xb1; 0.84<sup>f</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 1,<break/>Class 2 &gt; Class 1</td>
<td valign="middle" align="left">11.036</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">Other patients&#x2019; support</td>
<td valign="middle" align="left">7.19 &#xb1; 2.10</td>
<td valign="middle" align="left">7.14 &#xb1; 2.27</td>
<td valign="middle" align="left">7.09 &#xb1; 2.12</td>
<td valign="middle" align="left">7.49 &#xb1; 1.88</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">0.885</td>
<td valign="middle" align="left">0.414</td>
</tr>
<tr>
<td valign="middle" align="left">Self-management on disease</td>
<td valign="middle" align="left">13.46 &#xb1; 1.24</td>
<td valign="middle" align="left">13.42 &#xb1; 1.39</td>
<td valign="middle" align="left">13.45 &#xb1; 1.25</td>
<td valign="middle" align="left">13.53 &#xb1; 1.06</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">0.139</td>
<td valign="middle" align="left">0.871</td>
</tr>
<tr>
<td valign="middle" align="left">Positive cognition</td>
<td valign="middle" align="left">16.17 &#xb1; 1.87</td>
<td valign="middle" align="left">15.62 &#xb1; 2.12</td>
<td valign="middle" align="left">16.15 &#xb1; 1.90<sup>f</sup></td>
<td valign="middle" align="left">16.78 &#xb1; 1.24 <sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 2 &gt; Class 1</td>
<td valign="middle" align="left">6.737</td>
<td valign="middle" align="left">0.001</td>
</tr>
<tr>
<td valign="middle" align="left">Emotional regulation</td>
<td valign="middle" align="left">12.43 &#xb1; 1.73</td>
<td valign="middle" align="left">11.62 &#xb1; 1.31</td>
<td valign="middle" align="left">12.69 &#xb1; 1.79<sup>f</sup></td>
<td valign="middle" align="left">12.51 &#xb1; 1.72 <sup>fj</sup></td>
<td valign="middle" align="left">Class 2 &gt; Class 1,<break/>Class 3 &gt; Class 1</td>
<td valign="middle" align="left">9.865</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">Active response to difficulty</td>
<td valign="middle" align="left">17.62 &#xb1; 2.15</td>
<td valign="middle" align="left">17.71 &#xb1; 2.05</td>
<td valign="middle" align="left">17.53 &#xb1; 2.08</td>
<td valign="middle" align="left">17.76 &#xb1; 2.44</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">0.381</td>
<td valign="middle" align="left">0.684</td>
</tr>
<tr>
<td valign="middle" align="left">Overall social support score</td>
<td valign="middle" align="left">38.40 &#xb1; 5.63</td>
<td valign="middle" align="left">34.02 &#xb1; 2.92</td>
<td valign="middle" align="left">38.53 &#xb1; 5.75<sup>f</sup></td>
<td valign="middle" align="left">42.31 &#xb1; 4.14 <sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 2 &gt; Class 1</td>
<td valign="middle" align="left">47.091</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">Objective support</td>
<td valign="middle" align="left">9.24 &#xb1; 2.55</td>
<td valign="middle" align="left">9.08 &#xb1; 2.51</td>
<td valign="middle" align="left">9.13 &#xb1; 2.46</td>
<td valign="middle" align="left">9.72 &#xb1; 2.77</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">1.536</td>
<td valign="middle" align="left">0.217</td>
</tr>
<tr>
<td valign="middle" align="left">Subjective support</td>
<td valign="middle" align="left">22.34 &#xb1; 4.18</td>
<td valign="middle" align="left">21.15 &#xb1; 3.07</td>
<td valign="middle" align="left">22.11 &#xb1; 4.10</td>
<td valign="middle" align="left">24.12 &#xb1; 4.77 <sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 1,<break/>Class 3 &gt; Class 2</td>
<td valign="middle" align="left">9.597</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="left">Support availability</td>
<td valign="middle" align="left">7.25 &#xb1; 1.47</td>
<td valign="middle" align="left">6.86 &#xb1; 1.40</td>
<td valign="middle" align="left">7.19 &#xb1; 1.41</td>
<td valign="middle" align="left">7.81 &#xb1; 1.55 <sup>fj</sup></td>
<td valign="middle" align="left">Class 3 &gt; Class 1,<break/>Class 3 &gt; Class 2</td>
<td valign="middle" align="left">7.707</td>
<td valign="middle" align="left">&lt;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Data are <italic>Mean</italic> &#xb1; <italic>SD.</italic> Class 1 = low flourishing group, Class 2 = moderate flourishing group, Class 3 = high flourishing group.</p></fn>
<fn>
<p><sup>f</sup> Compared with Class 1, <italic>P &lt;</italic> 0.05. <sup>j</sup> Compared with Class 2, <italic>P</italic>&#x2009;&lt; 0.05.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Multivariate analysis results of potential profile categories in patients with IBD</title>
<p>In this study, the three potential profiles of flourishing in patients with IBD as dependent variables, while the statistically significant variables identified through univariate analysis served as independent variables. The results of the parallel line test indicated a <italic>p</italic>-value of less than 0.05, which did not satisfy the assumptions required for the application of the ordinal logistic regression model (<italic>p</italic> &gt; 0.05). Consequently, we selected the unordered logistic regression model for the multivariate analysis. The allocation of independent variables is detailed in <xref ref-type="table" rid="T4"><bold>Table&#xa0;4</bold></xref>. The multivariate analysis revealed that marital status, monthly household income, duration of diagnosis, scores for managing stress and emotions from the self-efficacy scale, scores for managing symptoms and disease, scores for maintaining remission, and scores for emotion regulation dimensions from the resilience scale were all significant predictors of the latent categories of flourishing among participants (all <italic>p</italic> &lt; 0.05) (see <xref ref-type="table" rid="T5"><bold>Table&#xa0;5</bold></xref>).</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Variable coding scheme.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Variable</th>
<th valign="middle" align="center">Assignment</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="middle" colspan="2" align="left">Marital status</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Married</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Unmarried or divorced or widowed</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Monthly household income (yuan)</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&lt;3000</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;3000 - &lt; 5000</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&#x2265; 5000</td>
<td valign="middle" align="center">3</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Duration of diagnosis (years)</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&lt;1</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;1 - &lt; 5</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&#x2265; 5</td>
<td valign="middle" align="center">3</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Current disease status</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Remission stage</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Mild active stage</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Moderate to severe active stage</td>
<td valign="middle" align="center">3</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">IBD-related complications</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;No</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Yes</td>
<td valign="middle" align="center">2</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Multivariate analysis of flourishing.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Item</th>
<th valign="middle" colspan="4" align="left">Class 2 vs Class 1</th>
<th valign="middle" colspan="4" align="left">Class 3 vs Class 1</th>
</tr>
<tr>
<th valign="middle" align="left"><italic>&#x3b2;</italic></th>
<th valign="middle" align="left"><italic>P</italic></th>
<th valign="middle" align="left"><italic>OR</italic></th>
<th valign="middle" align="left">95%<italic>CI</italic></th>
<th valign="middle" align="left"><italic>&#x3b2;</italic></th>
<th valign="middle" align="left"><italic>P</italic></th>
<th valign="middle" align="left"><italic>OR</italic></th>
<th valign="middle" align="left">95%<italic>CI</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">constant term</td>
<td valign="middle" align="left">-13.504</td>
<td valign="middle" align="left">0.066</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">-39.805</td>
<td valign="middle" align="left">&lt;0.001</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
<tr>
<th valign="middle" colspan="9" align="left">Marital status</th>
</tr>
<tr>
<td valign="middle" align="left">Married</td>
<td valign="middle" align="left">1.617</td>
<td valign="middle" align="left">0.003</td>
<td valign="middle" align="left">5.040</td>
<td valign="middle" align="left">1.731-14.678</td>
<td valign="middle" align="left">0.933</td>
<td valign="middle" align="left">0.191</td>
<td valign="middle" align="left">2.543</td>
<td valign="middle" align="left">0.628-10.305</td>
</tr>
<tr>
<td valign="middle" align="left">Unmarried or divorced or widowed</td>
<td valign="middle" align="left">Ref</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" colspan="9" align="left">Monthly household income(yuan)</th>
</tr>
<tr>
<td valign="middle" align="left">&lt; 3000</td>
<td valign="middle" align="left">-1.485</td>
<td valign="middle" align="left">0.032</td>
<td valign="middle" align="left">0.226</td>
<td valign="middle" align="left">0.058-0.882</td>
<td valign="middle" align="left">-1.925</td>
<td valign="middle" align="left">0.029</td>
<td valign="middle" align="left">0.146</td>
<td valign="middle" align="left">0.026-0.817</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2265; 5000</td>
<td valign="middle" align="left">Ref</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<th valign="middle" colspan="9" align="left">Duration of diagnosis(years)</th>
</tr>
<tr>
<td valign="middle" align="left">&lt; 1</td>
<td valign="middle" align="left">-1.902</td>
<td valign="middle" align="left">0.011</td>
<td valign="middle" align="left">0.149</td>
<td valign="middle" align="left">0.035-0.641</td>
<td valign="middle" align="left">-0.913</td>
<td valign="middle" align="left">0.347</td>
<td valign="middle" align="left">0.401</td>
<td valign="middle" align="left">0.060-2.689</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2265; 5</td>
<td valign="middle" align="left">Ref</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
<td valign="middle" align="left"/>
</tr>
<tr>
<td valign="middle" align="left">managing stress and emotions</td>
<td valign="middle" align="left">0.021</td>
<td valign="middle" align="left">0.687</td>
<td valign="middle" align="left">1.021</td>
<td valign="middle" align="left">0.921-1.133</td>
<td valign="middle" align="left">0.204</td>
<td valign="middle" align="left">&lt;0.001</td>
<td valign="middle" align="left">1.227</td>
<td valign="middle" align="left">1.087-1.385</td>
</tr>
<tr>
<td valign="middle" align="left">managing symptoms and disease</td>
<td valign="middle" align="left">0.138</td>
<td valign="middle" align="left">0.008</td>
<td valign="middle" align="left">1.147</td>
<td valign="middle" align="left">1.037-1.270</td>
<td valign="middle" align="left">0.183</td>
<td valign="middle" align="left">0.003</td>
<td valign="middle" align="left">1.201</td>
<td valign="middle" align="left">1.066-1.352</td>
</tr>
<tr>
<td valign="middle" align="left">maintaining remission</td>
<td valign="middle" align="left">0.282</td>
<td valign="middle" align="left">&lt;0.001</td>
<td valign="middle" align="left">1.325</td>
<td valign="middle" align="left">1.154-1.522</td>
<td valign="middle" align="left">0.324</td>
<td valign="middle" align="left">&lt;0.001</td>
<td valign="middle" align="left">1.383</td>
<td valign="middle" align="left">1.162-1.646</td>
</tr>
<tr>
<td valign="middle" align="left">Emotional regulation</td>
<td valign="middle" align="left">0.448</td>
<td valign="middle" align="left">0.002</td>
<td valign="middle" align="left">1.565</td>
<td valign="middle" align="left">1.182-2.071</td>
<td valign="middle" align="left">0.340</td>
<td valign="middle" align="left">0.048</td>
<td valign="middle" align="left">1.404</td>
<td valign="middle" align="left">1.003-1.965</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Pseudo R-Squares=0.635; The likelihood ratio chi-square test (<italic>&#x3c7;&#xb2;</italic> = 248.479, <italic>p</italic> &lt; 0.001).</p></fn>
<fn>
<p>Class 1 = low flourishing group, Class 2 = moderate flourishing group, Class 3 = high flourishing group.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In comparison to patients classified in the low flourishing group, married individuals with IBD exhibited a significantly higher likelihood of being categorized within the moderate flourishing group (OR = 5.040, <italic>p</italic> = 0.003). Furthermore, when compared to both the moderate flourishing group and the high flourishing group, IBD patients with a household per capita monthly income below 3000 demonstrated an increased probability of being classified in the low flourishing group (all <italic>p</italic> &lt; 0.05). Additionally, patients with a disease duration of less than one year were more likely to belong to the low flourishing group compared to those in the moderate flourishing group (OR = 0.149, <italic>p</italic> = 0.011). Moreover, IBD patients who scored higher in managing stress and emotions had an elevated probability of being included in the high flourishing group, in contrast to patients in the low flourishing group (OR = 1.227, <italic>p</italic> &lt; 0.001). Lastly, IBD patients achieving higher scores in managing symptoms and disease, maintaining remission, and emotion regulation were more likely to belong to both the moderate flourishing group and the high flourishing group compared to those in the low flourishing group (all <italic>p</italic> &lt; 0.05), as illustrated in <xref ref-type="table" rid="T5"><bold>Table&#xa0;5</bold></xref>. In addition, among the multiple logistic regression models employed in this study, the pseudo-R&#xb2; value was found to be 0.635, indicating that the core variables included account for 63.5% of the variation in the latent categories. The likelihood ratio chi-square test (<italic>&#x3c7;&#xb2;</italic> = 248.479, <italic>p</italic> &lt; 0.001) and the observed decrease in the -2 log likelihood value both substantiate that the model demonstrates a good fit and effectively captures the relationship between the independent variables and category assignment.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<sec id="s4_1">
<label>4.1</label>
<title>The flourishing of IBD patients can be categorized into three distinct latent profiles</title>
<p>This study identified three distinct latent profiles of flourishing among patients with IBD: a low flourishing group (20.9%), a moderate flourishing group (57.6%), and a high flourishing group (21.5%). These findings underscore the significant heterogeneity in flourishing levels within this population, thereby providing clear and targeted directions for clinical nursing interventions. Patients in the low flourishing group exhibit notable deficits in their perception of social support and a diminished self-recognition of life value. This vulnerability renders them susceptible to disease-related stress and undermines their confidence in adaptive behaviors. These observations are consistent with the findings of Travis, S.et al (<xref ref-type="bibr" rid="B57">57</xref>), which highlight the relationship between social support and psychological well-being in patients with chronic diseases. Healthcare providers should prioritize this group by designing tailored interventions. For instance, establishing peer support groups can enhance their social connections, while guiding family members to provide explicit emotional support is crucial. Additionally, initiating low-intensity disease management training can assist them in gradually building confidence in adaptive behaviors. The moderate flourishing group, which constitutes the largest proportion of participants, exhibits moderate overall flourishing but demonstrates a decline in optimism regarding the future. This decrease in optimism significantly affects their long-term adherence to adaptive behaviors. Therefore, healthcare providers should focus on addressing this deficit in optimism by organizing specialized lectures to educate patients about their disease prognosis. Additionally, guiding patients to establish short-term achievable health goals and helping them recognize the link between daily adaptive behaviors and goal attainment can enhance their motivation and adherence (<xref ref-type="bibr" rid="B58">58</xref>). Conversely, patients in the high flourishing group display strong social dignity and positive life attitudes; however, they may encounter challenges with adaptive behaviors in specific situations, such as sudden disease recurrence. This observation is consistent with the findings of Trindade, I. A. et&#xa0;al (<xref ref-type="bibr" rid="B59">59</xref>). on high-well-being chronic disease patients. To sustain their elevated level of flourishing, healthcare providers should develop personalized and adaptable interventions. For example, creating flexible health schedules that align with their daily routines and teaching practical skills, such as emotional regulation techniques (including deep breathing, mindfulness, and time management strategies), can help mitigate the impact of unforeseen circumstances on their adaptive behaviors.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>The impact of marital status on the flourishing of IBD patients</title>
<p>The results of this study indicated that marital status significantly influences the potential profile categories of flourishing in patients with IBD. Specifically, married patients were more likely to be categorized in the moderate flourishing group compared to their counterparts in the low flourishing group. This phenomenon can be attributed to the fact that married individuals typically enjoy more stable emotional companionship and practical support in their daily lives. Spouses can provide timely comfort during periods of illness-related distress, such as exacerbations of symptoms or treatment side effects, thereby helping patients mitigate negative emotions, such as anxiety and helplessness, which may impede flourishing. Furthermore, in terms of disease management, spouses often assist with medication reminders, dietary supervision, and accompany patients to medical appointments. These supports enhance patients&#x2019; sense of security and control over their condition, creating a favorable psychological foundation for maintaining moderate levels of flourishing. Conversely, unmarried or divorced patients may experience greater challenges in coping with illness alone, with fewer opportunities to share their physical and emotional burdens, which may contribute to their higher likelihood of being categorized in the low flourishing group. Sim. et&#xa0;al (<xref ref-type="bibr" rid="B60">60</xref>) further noted that singles often face greater familial pressure (e.g., marriage expectations), leading to psychological strain that undermines well-being These findings are consistent with prior research indicating the importance of marital relationships in health outcomes (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>). Therefore, it is essential to consider the role of marital relationships in promoting the flourishing of patients with IBD. For unmarried or divorced patients who may lack spousal companionship and practical support, healthcare providers can establish peer support groups to facilitate emotional exchange and experience sharing among patients. Additionally, they can connect these patients with social work services to supplement practical assistance in disease management, such as medication reminders and accompaniment to medical appointments.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>The impact of economic pressure on the flourishing of IBD patients</title>
<p>The results of this research indicated that, compared to the moderate flourishing group and the high flourishing group, IBD patients with a household monthly income per capita of less than 3000 were more likely to belong to the low flourishing group. aligning with the findings of Yu et&#xa0;al. (<xref ref-type="bibr" rid="B63">63</xref>). Given the chronic nature of IBD, lifelong treatment is often necessary; however, the treatment costs for IBD significantly exceed the average income level in China. This financial strain has led 76.1% of patients to either delay seeking medical care or independently reduce their medication due to financial constraints (<xref ref-type="bibr" rid="B63">63</xref>). Low treatment adherence can exacerbate disease symptoms, further increasing medical expenditures, intensifying patients&#x2019; psychological burden, and consequently reducing their overall well-being. Based on these findings, it is recommended that healthcare providers conduct thorough assessments of patients&#x2019; economic pressures. For those facing significant economic challenges, guidance on medical expense reimbursement options should be provided to enhance treatment adherence.</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>The impact of disease duration on the flourishing of IBD patients</title>
<p>This study also demonstrated that patients with a disease duration of less than one year were more likely to be classified into the low flourishing group compared to those in the moderate flourishing group. This finding indicates that patients with prolonged courses of IBD may exhibit higher levels of flourishing. This result is inconsistent with the conclusion of Qiu Meiqi et&#xa0;al. (<xref ref-type="bibr" rid="B64">64</xref>). The discrepancy may be attributed to differences in disease activity distribution between the two studies. In Qiu&#x2019;s sample, 58.4% of patients with long disease courses were in the moderate-to-severe active stage and experienced complications such as stenosis and fistulas. The persistent inflammatory burden may have directly impaired psychological adaptation. Conversely, in this study, the majority of long-disease-course patients were in the remission stage, where the accumulated coping resources from long-term disease management mitigated the physiological burden. On the contrary, patients in the early stage of IBD may still be in the adaptation phase to the disease; they often confront uncertainties regarding the disease&#x2019;s progression, treatment outcomes, and long-term impacts on daily life, which can evoke persistent anxiety, stress, or feelings of helplessness. These negative emotions directly undermine key components of flourishing, such as a sense of life meaning, emotional well-being, and interpersonal engagement. In contrast, patients with a longer disease duration may have accumulated more experience in disease management, established effective coping strategies, and gradually adjusted their life plans to accommodate the disease, thereby developing a more stable psychological state and higher levels of flourishing.</p>
<p>Based on these insights, it is recommended that healthcare professionals prioritize targeted psychological support for patients with IBD who have a short disease duration. This support may include providing disease-related education to clarify the chronic yet manageable nature of IBD, assisting patients in understanding the rationale behind treatment regimens, and alleviating anxiety regarding the uncertainties associated with the condition. Additionally, healthcare providers could facilitate connections between newly diagnosed patients and peer support groups consisting of individuals with longer disease durations, enabling them to gain practical disease management experiences and positive coping strategies through interpersonal interactions.</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>The impact of self-efficacy on the flourishing of IBD patients</title>
<p>The research findings indicated that self-efficacy scores for patients with IBD in our study exhibited distinct variations across the three flourishing profile categories. Specifically, compared to patients in the low flourishing group, those with higher scores in the managing stress and emotions dimension of self-efficacy were more likely to be classified into the high flourishing group. Furthermore, higher scores in both the managing symptoms and disease dimension and the maintaining remission dimension of the self-efficacy scale were positively correlated with higher flourishing levels, and they were more likely to be classified as part of the moderate flourishing group or the high flourishing group. These findings align with the self-efficacy theoretical framework in chronic disease management (<xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>Self-efficacy, as a core psychological resource for coping with chronic illnesses, shows differential associations with flourishing across its distinct functional dimensions (<xref ref-type="bibr" rid="B46">46</xref>). Higher efficacy in managing stress and emotions enables patients to regulate negative emotions more effectively, thereby preventing emotional distress from undermining their sense of life meaning and interpersonal engagement. For patients with IBD, the efficacy of managing stress and emotions primarily addresses the psychological distress caused by the uncertainty surrounding the disease. IBD is characterized by recurrent symptoms and unpredictable disease progression, which often induce persistent negative emotions such as anxiety, frustration, and fear of flare-ups (<xref ref-type="bibr" rid="B66">66</xref>). Patients with low efficacy in managing stress and emotions may find themselves trapped in a state of &#x201c;emotional paralysis.&#x201d; They might avoid social interactions due to fear of embarrassment stemming from their symptoms or lose motivation to pursue life goals, patterns that are linked to the social alienation and diminished sense of life meaning observed in the low flourishing group. Notably, research findings indicate that the dimensions of self-efficacy related to managing symptoms and maintaining remission have a more comprehensive impact on flourishing than those related to managing stress and emotions, as they directly address both physical disease control and psychological well-being (<xref ref-type="bibr" rid="B67">67</xref>). This underscores the importance of healthcare professionals designing targeted self-efficacy intervention programs for patients with IBD in our study. For instance, structured training sessions could be developed to improve patients&#x2019; skills in symptom monitoring and remission maintenance, while mindfulness-based stress reduction workshops could enhance their emotional regulation efficacy (<xref ref-type="bibr" rid="B68">68</xref>). Strengthening the dimensions of self-efficacy may represent a promising avenue for fostering positive psychological outcomes in patients with IBD. However, the effectiveness of such interventions necessitates validation through prospective studies. Furthermore, future research should employ longitudinal designs to elucidate the directional relationships between self-efficacy and flourishing, as well as to clarify the potential bidirectional influences between these constructs.</p>
</sec>
<sec id="s4_6">
<label>4.6</label>
<title>The impact of psychological resilience on the flourishing of IBD patients</title>
<p>The results of this study illustrated that the emotion regulation dimension of psychological resilience was a significant factor influencing the flourishing of patients with IBD in our study. Specifically, patients with higher scores in this dimension were more likely to be categorized into the moderate flourishing group or the high flourishing group. This finding aligns with the research conducted by Mendiolaza et&#xa0;al (<xref ref-type="bibr" rid="B69">69</xref>), which highlights the critical role of emotion regulation in adapting to chronic illnesses. As a core component of psychological resilience, emotion regulation encompasses patients&#x2019; abilities to recognize, process, and modulate negative emotions triggered by IBD-related stressors. The proficiency level in emotion regulation significantly affects patients&#x2019; flourishing status: those with stronger capacities can better mitigate emotional distress from symptom fluctuations, treatment burdens, or future uncertainties, while those with weaker regulation may experience intensified anxiety, frustration, or hopelessness, undermining their sense of life&#x2019;s meaning, interpersonal connection, and self-worth (<xref ref-type="bibr" rid="B70">70</xref>). Furthermore, IBD patients with effective emotion regulation tend to adopt more adaptive coping behaviors which contribute to higher levels of flourishing. These patients are less likely to be overwhelmed by negative emotions and are more inclined to engage in proactive actions that enhance their quality of life and disease control (<xref ref-type="bibr" rid="B71">71</xref>). Consequently, the dimension of emotion regulation within psychological resilience plays a pivotal role in shaping the flourishing outcomes of patients with IBD. This underscores the importance of healthcare providers incorporating emotion regulation training into flourishing-focused interventions. However, the effectiveness of such training in facilitating shifts toward moderate or high flourishing levels, as well as improving overall well-being, would require verification through prospective interventional studies.</p>
</sec>
<sec id="s4_7">
<label>4.7</label>
<title>Limitation</title>
<p>This study has several limitations that warrant acknowledgment. Firstly, as a cross-sectional study, it cannot investigate causal relationships or the cumulative effects among various influencing factors and the latent profile categories of flourishing. Additionally, participants were recruited from a single hospital, which may limit the generalizability of the findings. In addition, the pre-study sample size was relatively small. Despite validation evidence from patients with similar chronic diseases supporting the scale&#x2019;s applicability, large-sample confirmatory factor analysis and systematic criterion-related validity tests were lacking for the Chinese IBD patient cohort. Future research should expand the sample size to comprehensively verify the scale&#x2019;s full psychometric properties in this population, thereby providing a more robust methodological basis for assessing their psychological status. Secondly, the influencing factors of flourishing are likely to be complex and diverse, and this study did not comprehensively account for all relevant variables. Future research should focus on systematically exploring the multi-dimensional influencing factors of flourishing in patients with IBD, including negative psychological factors such as anxiety, depression, perceived stress, stigma, and post-traumatic stress disorder, as well as the severity of the disease, as well as potential confounding variables like disease severity, treatment regimens, and surgical history, which may help to more comprehensively reveal the mechanisms underlying the determinants of flourishing levels. Thirdly, it is important to acknowledge the specific limitations of the LPA method employed in this study. Due to sample size and distribution constraints, we were unable to conduct cross-validation or sample-specific validation. Although the total sample size was 316 participants, splitting the dataset would likely have resulted in subgroups that were too small to generate stable or convergent LPA solutions. Furthermore, since this study adopted a cross-sectional design, it was not possible to track the dynamic changes of various latent categories over time, which may render it difficult to fully confirm that these categories represent stable clinical phenotypes. Moreover, this study did not utilize independent clinical indicators or behavioral outcomes for external validation of the potential categories. Future research could potentially adopt a longitudinal design and incorporate independent clinical assessment tools and behavioral indicators to perform external validation. Finally, in direct comparisons between the first category (n = 66) and the third category (n = 68) using multiple regression analyses, the event per variable (EPV) ratio was found to be approximately 9.6. This value is lower than the traditionally recommended threshold, which may indicate a potential risk of model overfitting. Future research should aim to validate these findings by employing a larger sample size or alternatively by utilizing regularization techniques.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>This study utilized LPA to identify three distinct latent profiles of flourishing among IBD patients: a low flourishing group, a moderate flourishing group, and a high flourishing group. These findings underscore the significant heterogeneity in flourishing within this population. Furthermore, the study demonstrated that flourishing among IBD patients is significantly correlated with factors such as marital status, monthly household income, duration of diagnosis, the dimension of self-efficacy related to managing stress and emotions, the dimension related to managing symptoms and disease, the dimension pertaining to maintaining remission, and the emotion regulation dimension of psychological resilience. Healthcare professionals should implement more accurate and targeted intervention measures based on the characteristics and influencing factors of different potential categories, in order to improve the flourishing levels of patients with inflammatory bowel disease.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Material</bold></xref>. Further inquiries can be directed to the corresponding author.</p></sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>This study was conducted in accordance with the Declaration of Helsinki and received approval from the Ethics Committee of the Affiliated Hospital of Jiangnan University (Approval No. LS2025205). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p></sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>BL: Data curation, Formal Analysis, Conceptualization, Methodology, Writing &#x2013; original draft, Software, Investigation. LM: Validation, Software, Writing &#x2013; original draft, Data curation, Conceptualization, Investigation. FX: Writing &#x2013; review &amp; editing, Methodology. LZ: Writing &#x2013; review &amp; editing, Data curation, Validation. YL: Writing &#x2013; review &amp; editing, Software. XY: Writing &#x2013; review &amp; editing, Validation. RS: Project administration, Resources, Writing &#x2013; review &amp; editing, Supervision. YFL: Funding acquisition, Writing &#x2013; original draft, Project administration, Supervision.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>The authors thank all participants in this study for their support.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1751497/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1751497/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hodson</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Inflammatory bowel disease</article-title>. <source>Nature</source>. (<year>2016</year>) <volume>540</volume>:<elocation-id>S97</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/540S97a</pub-id>, PMID: <pub-id pub-id-type="pmid">28002398</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hemmer</surname> <given-names>A</given-names></name>
<name><surname>Forest</surname> <given-names>K</given-names></name>
<name><surname>Rath</surname> <given-names>J</given-names></name>
<name><surname>Bowman</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Inflammatory bowel disease: A concise review</article-title>. <source>S D Med</source>. (<year>2023</year>) <volume>76</volume>:<page-range>416&#x2013;23</page-range>., PMID: <pub-id pub-id-type="pmid">37738497</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yunli</surname> <given-names>B</given-names></name>
<name><surname>Zhe</surname> <given-names>W</given-names></name>
<name><surname>Hairu</surname> <given-names>T</given-names></name>
<name><surname>Na</surname> <given-names>L</given-names></name>
<name><surname>Ying</surname> <given-names>Z</given-names></name>
<name><surname>Bin</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>Disease burden and variation tendency of inflammatory bowel disease in China from 1990 to 2019</article-title>. <source>Chin Gen Pract</source>. (<year>2023</year>) <volume>26</volume>:<page-range>4581&#x2013;6</page-range>.
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gordon</surname> <given-names>H</given-names></name>
<name><surname>Burisch</surname> <given-names>J</given-names></name>
<name><surname>Ellul</surname> <given-names>P</given-names></name>
<name><surname>Karmiris</surname> <given-names>K</given-names></name>
<name><surname>Katsanos</surname> <given-names>K</given-names></name>
<name><surname>Allocca</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease</article-title>. <source>J Crohns Colitis</source>. (<year>2024</year>) <volume>18</volume>:<fpage>1</fpage>&#x2013;<lpage>37</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ecco-jcc/jjad108</pub-id>, PMID: <pub-id pub-id-type="pmid">37351850</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bisgaard</surname> <given-names>TH</given-names></name>
<name><surname>Allin</surname> <given-names>KH</given-names></name>
<name><surname>Keefer</surname> <given-names>L</given-names></name>
<name><surname>Ananthakrishnan</surname> <given-names>AN</given-names></name>
<name><surname>Jess</surname> <given-names>T</given-names></name>
</person-group>. 
<article-title>Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. (<year>2022</year>) <volume>19</volume>:<page-range>717&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41575-022-00634-6</pub-id>, PMID: <pub-id pub-id-type="pmid">35732730</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>Q</given-names></name>
<name><surname>Gu</surname> <given-names>J</given-names></name>
<name><surname>Lin</surname> <given-names>Z</given-names></name>
<name><surname>Li</surname> <given-names>S</given-names></name>
<name><surname>Zhou</surname> <given-names>M</given-names></name>
<name><surname>Yang</surname> <given-names>J</given-names></name>
<etal/>
</person-group>. 
<article-title>Social alienation in patients with inflammatory bowel diseases: A latent profile analysis</article-title>. <source>Int J Nurs Sci</source>. (<year>2025</year>) <volume>12</volume>:<page-range>335&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijnss.2025.06.007</pub-id>, PMID: <pub-id pub-id-type="pmid">40786861</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Balestrieri</surname> <given-names>P</given-names></name>
<name><surname>Cicala</surname> <given-names>M</given-names></name>
<name><surname>Ribolsi</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Psychological distress in inflammatory bowel disease</article-title>. <source>Expert Rev Gastroenterol Hepatol</source>. (<year>2023</year>) <volume>17</volume>:<page-range>539&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/17474124.2023.2209723</pub-id>, PMID: <pub-id pub-id-type="pmid">37254523</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gonz&#xe1;lez-Moret</surname> <given-names>R</given-names></name>
<name><surname>Cebolla-Mart&#xed;</surname> <given-names>A</given-names></name>
<name><surname>Almod&#xf3;var-Fern&#xe1;ndez</surname> <given-names>I</given-names></name>
<name><surname>Navarrete</surname> <given-names>J</given-names></name>
<name><surname>Garc&#xed;a-Esparza</surname> <given-names>&#xc1;</given-names></name>
<name><surname>Soria</surname> <given-names>JM</given-names></name>
<etal/>
</person-group>. 
<article-title>Inflammatory biomarkers and psychological variables to assess quality of life in patients with inflammatory bowel disease: a cross-sectional study</article-title>. <source>Ann Med</source>. (<year>2024</year>) <volume>56</volume>:<elocation-id>2357738</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/07853890.2024.2357738</pub-id>, PMID: <pub-id pub-id-type="pmid">38819080</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bonaz</surname> <given-names>BL</given-names></name>
<name><surname>Bernstein</surname> <given-names>CN</given-names></name>
</person-group>. 
<article-title>Brain-gut interactions in inflammatory bowel disease</article-title>. <source>Gastroenterology</source>. (<year>2013</year>) <volume>144</volume>:<fpage>36</fpage>&#x2013;<lpage>49</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2012.10.003</pub-id>, PMID: <pub-id pub-id-type="pmid">23063970</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Graff</surname> <given-names>LA</given-names></name>
<name><surname>Geist</surname> <given-names>R</given-names></name>
<name><surname>Kuenzig</surname> <given-names>ME</given-names></name>
<name><surname>Benchimol</surname> <given-names>EI</given-names></name>
<name><surname>Kaplan</surname> <given-names>GG</given-names></name>
<name><surname>Windsor</surname> <given-names>JW</given-names></name>
<etal/>
</person-group>. 
<article-title>The 2023 impact of inflammatory bowel disease in Canada: mental health and inflammatory bowel disease</article-title>. <source>J Can Assoc Gastroenterol</source>. (<year>2023</year>) <volume>6</volume>:<fpage>S64</fpage>&#x2013;<lpage>s75</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jcag/gwad012</pub-id>, PMID: <pub-id pub-id-type="pmid">37674499</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sehgal</surname> <given-names>P</given-names></name>
<name><surname>Ungaro</surname> <given-names>RC</given-names></name>
<name><surname>Foltz</surname> <given-names>C</given-names></name>
<name><surname>Iacoviello</surname> <given-names>B</given-names></name>
<name><surname>Dubinsky</surname> <given-names>MC</given-names></name>
<name><surname>Keefer</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>High levels of psychological resilience associated with less disease activity, better quality of life, and fewer surgeries in inflammatory bowel disease</article-title>. <source>Inflammation Bowel Dis</source>. (<year>2021</year>) <volume>27</volume>:<page-range>791&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ibd/izaa196</pub-id>, PMID: <pub-id pub-id-type="pmid">32696966</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Philippou</surname> <given-names>A</given-names></name>
<name><surname>Sehgal</surname> <given-names>P</given-names></name>
<name><surname>Ungaro</surname> <given-names>RC</given-names></name>
<name><surname>Wang</surname> <given-names>K</given-names></name>
<name><surname>Bagiella</surname> <given-names>E</given-names></name>
<name><surname>Dubinsky</surname> <given-names>MC</given-names></name>
<etal/>
</person-group>. 
<article-title>High levels of psychological resilience are associated with decreased anxiety in inflammatory bowel disease</article-title>. <source>Inflammation Bowel Dis</source>. (<year>2022</year>) <volume>28</volume>:<page-range>888&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ibd/izab200</pub-id>, PMID: <pub-id pub-id-type="pmid">34448855</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sauk</surname> <given-names>JS</given-names></name>
<name><surname>Ryu</surname> <given-names>HJ</given-names></name>
<name><surname>Labus</surname> <given-names>JS</given-names></name>
<name><surname>Khandadash</surname> <given-names>A</given-names></name>
<name><surname>Ahdoot</surname> <given-names>AI</given-names></name>
<name><surname>Lagishetty</surname> <given-names>V</given-names></name>
<etal/>
</person-group>. 
<article-title>High perceived stress is associated with increased risk of ulcerative colitis clinical flares</article-title>. <source>Clin Gastroenterol Hepatol</source>. (<year>2023</year>) <volume>21</volume>:<fpage>741</fpage>&#x2013;<lpage>749.e743</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cgh.2022.07.025</pub-id>, PMID: <pub-id pub-id-type="pmid">35952942</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wong</surname> <given-names>PTP</given-names></name>
<name><surname>Ho</surname> <given-names>LS</given-names></name>
<name><surname>Mayer</surname> <given-names>CH</given-names></name>
<name><surname>Yang</surname> <given-names>F</given-names></name>
<name><surname>Cowden</surname> <given-names>RG</given-names></name>
</person-group>. 
<article-title>Editorial: A new science of suffering, the wisdom of the soul, and the new behavioral economics of happiness: towards a general theory of well-being</article-title>. <source>Front Psychol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1280613</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyg.2023.1280613</pub-id>, PMID: <pub-id pub-id-type="pmid">37809317</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Seligman</surname> <given-names>MEP</given-names></name>
<name><surname>Brealey</surname> <given-names>N</given-names></name>
</person-group>. <source>Flourish: a new understanding of happiness and well-being - and how to achieve them</source>. <publisher-loc>New York</publisher-loc>: 
<publisher-name>Free Press</publisher-name> (<year>2011</year>).
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Fei</surname> <given-names>Z</given-names></name>
</person-group>. <source>Investigation and analysis of mental health status of ICU medical staff in Bengbu 3A general hospital</source>. <publisher-loc>Jinan</publisher-loc>: 
<publisher-name>Shandong University</publisher-name> (<year>2018</year>).
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cerezo</surname> <given-names>MV</given-names></name>
<name><surname>Soria-Reyes</surname> <given-names>LM</given-names></name>
<name><surname>Alarc&#xf3;n</surname> <given-names>R</given-names></name>
<name><surname>Blanca</surname> <given-names>MJ</given-names></name>
</person-group>. 
<article-title>The Satisfaction with Life Scale in breast cancer patients: Psychometric properties</article-title>. <source>Int J Clin Health Psychol</source>. (<year>2022</year>) <volume>22</volume>:<elocation-id>100274</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijchp.2021.100274</pub-id>, PMID: <pub-id pub-id-type="pmid">34703465</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Parekh</surname> <given-names>NK</given-names></name>
<name><surname>McMaster</surname> <given-names>K</given-names></name>
<name><surname>Nguyen</surname> <given-names>DL</given-names></name>
<name><surname>Shah</surname> <given-names>S</given-names></name>
<name><surname>Speziale</surname> <given-names>A</given-names></name>
<name><surname>Miller</surname> <given-names>J</given-names></name>
<etal/>
</person-group>. 
<article-title>Coping strategies used by adult patients with inflammatory bowel disease</article-title>. <source>South Med J</source>. (<year>2015</year>) <volume>108</volume>:<page-range>337&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14423/smj.0000000000000292</pub-id>, PMID: <pub-id pub-id-type="pmid">26079458</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Taft</surname> <given-names>TH</given-names></name>
<name><surname>Ballou</surname> <given-names>S</given-names></name>
<name><surname>Bedell</surname> <given-names>A</given-names></name>
<name><surname>Lincenberg</surname> <given-names>D</given-names></name>
</person-group>. 
<article-title>Psychological considerations and interventions in inflammatory bowel disease patient care</article-title>. <source>Gastroenterol Clin North Am</source>. (<year>2017</year>) <volume>46</volume>:<page-range>847&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.gtc.2017.08.007</pub-id>, PMID: <pub-id pub-id-type="pmid">29173526</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>J</given-names></name>
<name><surname>Liu</surname> <given-names>C</given-names></name>
<name><surname>An</surname> <given-names>P</given-names></name>
<name><surname>Chen</surname> <given-names>M</given-names></name>
<name><surname>Wei</surname> <given-names>Y</given-names></name>
<name><surname>Li</surname> <given-names>J</given-names></name>
<etal/>
</person-group>. 
<article-title>Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study</article-title>. <source>United Eur Gastroenterol J</source>. (<year>2024</year>) <volume>12</volume>:<page-range>374&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ueg2.12532</pub-id>, PMID: <pub-id pub-id-type="pmid">38315582</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yi</surname> <given-names>X</given-names></name>
<name><surname>Liu</surname> <given-names>X</given-names></name>
<name><surname>Huang</surname> <given-names>C</given-names></name>
<name><surname>Wu</surname> <given-names>S</given-names></name>
<name><surname>Ye</surname> <given-names>Y</given-names></name>
<name><surname>Lin</surname> <given-names>C</given-names></name>
<etal/>
</person-group>. 
<article-title>Research progress on flourishing theory and the dual-factor model of mental health based on the perspective of positive psychology</article-title>. <source>Chin Evidence-Based Nurs</source>. (<year>2022</year>) <volume>8</volume>:<page-range>3038&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.12102/ji.ssn.2095-8668.2022.22.007</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Bandura</surname> <given-names>A</given-names></name>
</person-group>. <source>Self-efficacy: The exercise of control</source>. <publisher-loc>Henry Holt &amp; Co</publisher-loc>: 
<publisher-name>W H Freeman</publisher-name> (<year>1997</year>).
</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sheehan</surname> <given-names>JL</given-names></name>
<name><surname>Greene-Higgs</surname> <given-names>L</given-names></name>
<name><surname>Swanson</surname> <given-names>L</given-names></name>
<name><surname>Higgins</surname> <given-names>PDR</given-names></name>
<name><surname>Krein</surname> <given-names>SL</given-names></name>
<name><surname>Waljee</surname> <given-names>AK</given-names></name>
<etal/>
</person-group>. 
<article-title>Self-efficacy and the impact of inflammatory bowel disease on patients&#x2019; Daily lives</article-title>. <source>Clin Transl Gastroenterol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>e00577</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.14309/ctg.0000000000000577</pub-id>, PMID: <pub-id pub-id-type="pmid">36881812</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mikocka-Walus</surname> <given-names>A</given-names></name>
<name><surname>Knowles</surname> <given-names>SR</given-names></name>
<name><surname>Keefer</surname> <given-names>L</given-names></name>
<name><surname>Graff</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Controversies revisited: A systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases</article-title>. <source>Inflammation Bowel Dis</source>. (<year>2016</year>) <volume>22</volume>:<page-range>752&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/mib.0000000000000620</pub-id>, PMID: <pub-id pub-id-type="pmid">26841224</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Barberio</surname> <given-names>B</given-names></name>
<name><surname>Zamani</surname> <given-names>M</given-names></name>
<name><surname>Black</surname> <given-names>CJ</given-names></name>
<name><surname>Savarino</surname> <given-names>EV</given-names></name>
<name><surname>Ford</surname> <given-names>AC</given-names></name>
</person-group>. 
<article-title>Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis</article-title>. <source>Lancet Gastroenterol Hepatol</source>. (<year>2021</year>) <volume>6</volume>:<page-range>359&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s2468-1253(21)00014-5</pub-id>, PMID: <pub-id pub-id-type="pmid">33721557</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Eindor-Abarbanel</surname> <given-names>A</given-names></name>
<name><surname>Naftali</surname> <given-names>T</given-names></name>
<name><surname>Ruhimovich</surname> <given-names>N</given-names></name>
<name><surname>Bar-Gil Shitrit</surname> <given-names>A</given-names></name>
<name><surname>Sklerovsky-Benjaminov</surname> <given-names>F</given-names></name>
<name><surname>Konikoff</surname> <given-names>F</given-names></name>
<etal/>
</person-group>. 
<article-title>Important relation between self-efficacy, sense of coherence, illness perceptions, depression and anxiety in patients with inflammatory bowel disease</article-title>. <source>Frontline Gastroenterol</source>. (<year>2021</year>) <volume>12</volume>:<page-range>601&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/flgastro-2020-101412</pub-id>, PMID: <pub-id pub-id-type="pmid">34917318</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rutter</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Resilience in the face of adversity. Protective factors and resistance to psychiatric disorder</article-title>. <source>Br J Psychiatry</source>. (<year>1985</year>) <volume>147</volume>:<fpage>598</fpage>&#x2013;<lpage>611</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1192/bjp.147.6.598</pub-id>, PMID: <pub-id pub-id-type="pmid">3830321</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chuning</surname> <given-names>AE</given-names></name>
<name><surname>Durham</surname> <given-names>MR</given-names></name>
<name><surname>Killgore</surname> <given-names>WDS</given-names></name>
<name><surname>Smith</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Psychological resilience and hardiness as protective factors in the relationship between depression/anxiety and well-being: exploratory and confirmatory evidence</article-title>. <source>Pers Individ Dif</source>. (<year>2024</year>) <volume>225</volume>:<elocation-id>112664</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.paid.2024.112664</pub-id>, PMID: <pub-id pub-id-type="pmid">38706834</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Giri</surname> <given-names>S</given-names></name>
<name><surname>Harindranath</surname> <given-names>S</given-names></name>
<name><surname>Chandnani</surname> <given-names>S</given-names></name>
<name><surname>Jena</surname> <given-names>A</given-names></name>
<name><surname>Sharma</surname> <given-names>V</given-names></name>
<name><surname>Sebastian</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>Systematic review: stigma associated with inflammatory bowel disease</article-title>. <source>Aliment Pharmacol Ther</source>. (<year>2025</year>) <volume>62</volume>:<page-range>11&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/apt.70448</pub-id>, PMID: <pub-id pub-id-type="pmid">41186070</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ferrarese</surname> <given-names>D</given-names></name>
<name><surname>Spagnolo</surname> <given-names>G</given-names></name>
<name><surname>Vecchione</surname> <given-names>M</given-names></name>
<name><surname>Scaldaferri</surname> <given-names>F</given-names></name>
<name><surname>Armuzzi</surname> <given-names>A</given-names></name>
<name><surname>Chieffo</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease: A case-control study</article-title>. <source>Dig Dis</source>. (<year>2022</year>) <volume>40</volume>:<page-range>701&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000521424</pub-id>, PMID: <pub-id pub-id-type="pmid">34923490</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shinn</surname> <given-names>M</given-names></name>
<name><surname>Lehmann</surname> <given-names>S</given-names></name>
<name><surname>Wong</surname> <given-names>NW</given-names></name>
</person-group>. 
<article-title>Social interaction and social support</article-title>. <source>J Soc Issues</source>. (<year>2010</year>) <volume>40</volume>:<fpage>55</fpage>&#x2013;<lpage>76</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1540-4560.1984.tb01107.x</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fu</surname> <given-names>S</given-names></name>
<name><surname>Liu</surname> <given-names>Z</given-names></name>
<name><surname>Cui</surname> <given-names>Y</given-names></name>
</person-group>. 
<article-title>The mediating effect of psychological coherence in young and middle-aged patients with first-episode stroke in understanding social support and post-traumatic stress disorder</article-title>. <source>Chin J Nurs</source>. (<year>2023</year>) <volume>30</volume>:<page-range>43&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.16460/j.issn1008-9969.2023.20.043</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bhandari</surname> <given-names>S</given-names></name>
<name><surname>Larson</surname> <given-names>ME</given-names></name>
<name><surname>Kumar</surname> <given-names>N</given-names></name>
<name><surname>Stein</surname> <given-names>D</given-names></name>
</person-group>. 
<article-title>Association of inflammatory bowel disease (IBD) with depressive symptoms in the United States population and independent predictors of depressive symptoms in an IBD population: A NHANES study</article-title>. <source>Gut Liver</source>. (<year>2017</year>) <volume>11</volume>:<page-range>512&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.5009/gnl16347</pub-id>, PMID: <pub-id pub-id-type="pmid">28395506</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>W</given-names></name>
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
<name><surname>Xu</surname> <given-names>G</given-names></name>
<name><surname>Wu</surname> <given-names>J</given-names></name>
<name><surname>Yang</surname> <given-names>M</given-names></name>
<name><surname>Fang</surname> <given-names>X</given-names></name>
<etal/>
</person-group>. 
<article-title>Profiles of disease burden in patients with inflammatory bowel disease and the impact on psychosocial adaptation</article-title>. <source>Nurs Health Sci</source>. (<year>2025</year>) <volume>27</volume>:<fpage>e70083</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/nhs.70083</pub-id>, PMID: <pub-id pub-id-type="pmid">40107667</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>Y</given-names></name>
<name><surname>Han</surname> <given-names>S</given-names></name>
<name><surname>Shi</surname> <given-names>Y</given-names></name>
<name><surname>Chen</surname> <given-names>M</given-names></name>
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
<name><surname>Wu</surname> <given-names>K</given-names></name>
</person-group>. 
<article-title>Psychological status and influencing factors of patients with inflammatory bowel disease</article-title>. <source>Chin J Gastroenterol</source>. (<year>2020</year>) <volume>25</volume>:<page-range>454&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3969/j.issn.1008-7125.2020.08.002</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname> <given-names>G</given-names></name>
<name><surname>Liu</surname> <given-names>T</given-names></name>
<name><surname>Jiang</surname> <given-names>Y</given-names></name>
<name><surname>Xu</surname> <given-names>Y</given-names></name>
<name><surname>Zheng</surname> <given-names>T</given-names></name>
<name><surname>Li</surname> <given-names>X</given-names></name>
</person-group>. 
<article-title>Heterogeneity in psychological adaptation patterns and its predictive factors among patients with inflammatory bowel disease: A latent profile analysis</article-title>. <source>Psychol Res Behav Manag</source>. (<year>2024</year>) <volume>17</volume>:<page-range>219&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/prbm.S438973</pub-id>, PMID: <pub-id pub-id-type="pmid">38269258</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kongsted</surname> <given-names>A</given-names></name>
<name><surname>Nielsen</surname> <given-names>AM</given-names></name>
</person-group>. 
<article-title>Latent Class Analysis in health research</article-title>. <source>J Physiother</source>. (<year>2017</year>) <volume>63</volume>:<page-range>55&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jphys.2016.05.018</pub-id>, PMID: <pub-id pub-id-type="pmid">27914733</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lichtenstein</surname> <given-names>GR</given-names></name>
<name><surname>Loftus</surname> <given-names>EV</given-names></name>
<name><surname>Afzali</surname> <given-names>A</given-names></name>
<name><surname>Long</surname> <given-names>MD</given-names></name>
<name><surname>Barnes</surname> <given-names>EL</given-names></name>
<name><surname>Isaacs</surname> <given-names>KL</given-names></name>
<etal/>
</person-group>. 
<article-title>ACG clinical guideline: management of Crohn&#x2019;s disease in adults</article-title>. <source>Am J Gastroenterol</source>. (<year>2025</year>) <volume>120</volume>:<page-range>1225&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14309/ajg.0000000000003465</pub-id>, PMID: <pub-id pub-id-type="pmid">40701562</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Langa</surname> <given-names>KM</given-names></name>
<name><surname>Levine</surname> <given-names>DA</given-names></name>
</person-group>. 
<article-title>The diagnosis and management of mild cognitive impairment: a clinical review</article-title>. <source>Jama</source>. (<year>2014</year>) <volume>312</volume>:<page-range>2551&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jama.2014.13806</pub-id>, PMID: <pub-id pub-id-type="pmid">25514304</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Hair</surname> <given-names>JF</given-names></name>
<name><surname>Black</surname> <given-names>WC</given-names></name>
<name><surname>Babin</surname> <given-names>BJ</given-names></name>
<name><surname>RE.</surname> <given-names>A</given-names></name>
</person-group>. <source>Multivariate data analysis. eighthed</source>. <publisher-loc>London</publisher-loc>: 
<publisher-name>Cengage Learning</publisher-name> (<year>2019</year>).
</mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ferguson</surname> <given-names>SL</given-names></name>
<name><surname>Moore</surname> <given-names>WG</given-names></name>
<name><surname>Hull</surname> <given-names>DM</given-names></name>
</person-group>. 
<article-title>Finding latent groups in observed data: A primer on latent profile analysis in Mplus for applied researchers</article-title>. <source>Int J Behav Dev</source>. (<year>2019</year>) <volume>44</volume>:<fpage>5</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0165025419881721</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Walmsley</surname> <given-names>RS</given-names></name>
<name><surname>Ayres</surname> <given-names>RC</given-names></name>
<name><surname>Pounder</surname> <given-names>RE</given-names></name>
<name><surname>Allan</surname> <given-names>RN</given-names></name>
</person-group>. 
<article-title>A simple clinical colitis activity index</article-title>. <source>Gut</source>. (<year>1998</year>) <volume>43</volume>:<fpage>29</fpage>&#x2013;<lpage>32</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gut.43.1.29</pub-id>, PMID: <pub-id pub-id-type="pmid">9771402</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Harvey</surname> <given-names>RF</given-names></name>
<name><surname>Bradshaw</surname> <given-names>JM</given-names></name>
</person-group>. 
<article-title>A simple index of Crohn&#x2019;s-disease activity</article-title>. <source>Lancet</source>. (<year>1980</year>) <volume>1</volume>:<fpage>514</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(80)92767-1</pub-id>, PMID: <pub-id pub-id-type="pmid">6102236</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Diener</surname> <given-names>E</given-names></name>
<name><surname>Seligman</surname> <given-names>MEP</given-names></name>
<name><surname>Choi</surname> <given-names>H</given-names></name>
<name><surname>Oishi</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>Happiest people revisited</article-title>. <source>Perspect Psychol Sci</source>. (<year>2018</year>) <volume>13</volume>:<page-range>176&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1745691617697077</pub-id>, PMID: <pub-id pub-id-type="pmid">29592642</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Lai</surname> <given-names>Q</given-names></name>
</person-group>. <source>Study on College Student&#x2019;s Flourish Condition and its Application in the Dual-factor Model of Mental Health</source>. <publisher-loc>Guangzhou</publisher-loc>: 
<publisher-name>Southern Medical University</publisher-name> (<year>2017</year>).
</mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Keefer</surname> <given-names>L</given-names></name>
<name><surname>Kiebles</surname> <given-names>JL</given-names></name>
<name><surname>Taft</surname> <given-names>TH</given-names></name>
</person-group>. 
<article-title>The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure</article-title>. <source>Inflammation Bowel Dis</source>. (<year>2011</year>) <volume>17</volume>:<page-range>614&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ibd.21314</pub-id>, PMID: <pub-id pub-id-type="pmid">20848516</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tu</surname> <given-names>W</given-names></name>
<name><surname>Xu</surname> <given-names>G</given-names></name>
</person-group>. 
<article-title>Reliability and validity of the Chinese version of Inflammatory Bowel Disease Self-Efficacy Scale</article-title>. <source>Chin J Pract Nurs</source>. (<year>2014</year>) <volume>30</volume>:<fpage>18</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3760/cma.j.issn.1672-7088.2014.22.006</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Luo</surname> <given-names>D</given-names></name>
</person-group>. <source>The development and psychometric assessment of the strength and resilience scale for inflammatory bowel disease</source>. <publisher-loc>Nanjing</publisher-loc>: 
<publisher-name>Nanjing Medical University</publisher-name> (<year>2018</year>).
</mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xiao</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>Theoretical basis and research application of social support rating scale</article-title>. <source>J Clin Psychiatry</source>. (<year>1994</year>) <volume>4</volume>:<fpage>98</fpage>&#x2013;<lpage>100</lpage>. doi:&#xa0;CNKI:SUN:LCJS.0.1994-02-019

</mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McHorney</surname> <given-names>CA</given-names></name>
<name><surname>Tarlov</surname> <given-names>AR</given-names></name>
</person-group>. 
<article-title>Individual-patient monitoring in clinical practice: are available health status surveys adequate</article-title>? <source>Qual Life Res</source>. (<year>1995</year>) <volume>4</volume>:<fpage>293</fpage>&#x2013;<lpage>307</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/bf01593882</pub-id>, PMID: <pub-id pub-id-type="pmid">7550178</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Podsakoff</surname> <given-names>PM</given-names></name>
<name><surname>MacKenzie</surname> <given-names>SB</given-names></name>
<name><surname>Lee</surname> <given-names>JY</given-names></name>
<name><surname>Podsakoff</surname> <given-names>NP</given-names></name>
</person-group>. 
<article-title>Common method biases in behavioral research: a critical review of the literature and recommended remedies</article-title>. <source>J Appl Psychol</source>. (<year>2003</year>) <volume>88</volume>:<fpage>879</fpage>&#x2013;<lpage>903</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1037/0021-9010.88.5.879</pub-id>, PMID: <pub-id pub-id-type="pmid">14516251</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mishra</surname> <given-names>P</given-names></name>
<name><surname>Pandey</surname> <given-names>CM</given-names></name>
<name><surname>Singh</surname> <given-names>U</given-names></name>
<name><surname>Gupta</surname> <given-names>A</given-names></name>
<name><surname>Sahu</surname> <given-names>C</given-names></name>
<name><surname>Keshri</surname> <given-names>A</given-names></name>
</person-group>. 
<article-title>Descriptive statistics and normality tests for statistical data</article-title>. <source>Ann Card Anaesth</source>. (<year>2019</year>) <volume>22</volume>:<fpage>67</fpage>&#x2013;<lpage>72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/aca.ACA_157_18</pub-id>, PMID: <pub-id pub-id-type="pmid">30648682</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vatcheva</surname> <given-names>KP</given-names></name>
<name><surname>Lee</surname> <given-names>M</given-names></name>
<name><surname>McCormick</surname> <given-names>JB</given-names></name>
<name><surname>Rahbar</surname> <given-names>MH</given-names></name>
</person-group>. 
<article-title>Multicollinearity in regression analyses conducted in epidemiologic studies</article-title>. <source>Epidemiol (Sunnyvale)</source>. (<year>2016</year>) <volume>6</volume>:<elocation-id>227</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.4172/2161-1165.1000227</pub-id>, PMID: <pub-id pub-id-type="pmid">27274911</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schlomer</surname> <given-names>GL</given-names></name>
<name><surname>Bauman</surname> <given-names>S</given-names></name>
<name><surname>Card</surname> <given-names>NA</given-names></name>
</person-group>. 
<article-title>Best practices for missing data management in counseling psychology</article-title>. <source>J Couns Psychol</source>. (<year>2010</year>) <volume>57</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1037/a0018082</pub-id>, PMID: <pub-id pub-id-type="pmid">21133556</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wen</surname> <given-names>ZL</given-names></name>
<name><surname>Huang</surname> <given-names>BB</given-names></name>
<name><surname>DD</surname> <given-names>T</given-names></name>
</person-group>. 
<article-title>Preparation for questionnaire data modeling</article-title>. <source>J psychol Sci</source>. (<year>2018</year>) <volume>41</volume>:<page-range>204&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.16719/j.cnki.1671-6981.20180130</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kr&#xf6;meke</surname> <given-names>A</given-names></name>
<name><surname>Shani</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Flourishing in life in patients with Inflammatory Bowel Disease: The role of illness identity and health-related quality of life</article-title>. <source>J Health Psychol</source>. (<year>2025</year>) <volume>30</volume>:<page-range>1089&#x2013;103</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/13591053241260288</pub-id>, PMID: <pub-id pub-id-type="pmid">39054613</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Travis</surname> <given-names>S</given-names></name>
<name><surname>Potts Bleakman</surname> <given-names>A</given-names></name>
<name><surname>Dubinsky</surname> <given-names>MC</given-names></name>
<name><surname>Schreiber</surname> <given-names>S</given-names></name>
<name><surname>Panaccione</surname> <given-names>R</given-names></name>
<name><surname>Hibi</surname> <given-names>T</given-names></name>
<etal/>
</person-group>. 
<article-title>The communicating needs and features of IBD experiences (CONFIDE) study: US and european patient and health care professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis</article-title>. <source>Inflammation Bowel Dis</source>. (<year>2024</year>) <volume>30</volume>:<page-range>939&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ibd/izad142</pub-id>, PMID: <pub-id pub-id-type="pmid">37603837</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>De Sousa</surname> <given-names>JFM</given-names></name>
<name><surname>Paghdar</surname> <given-names>S</given-names></name>
<name><surname>Khan</surname> <given-names>TM</given-names></name>
<name><surname>Patel</surname> <given-names>NP</given-names></name>
<name><surname>Chandrasekaran</surname> <given-names>S</given-names></name>
<name><surname>Tsouklidis</surname> <given-names>N</given-names></name>
</person-group>. 
<article-title>Stress and inflammatory bowel disease: clear mind, happy colon</article-title>. <source>Cureus</source>. (<year>2022</year>) <volume>14</volume>:<fpage>e25006</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7759/cureus.25006</pub-id>, PMID: <pub-id pub-id-type="pmid">35582022</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Trindade</surname> <given-names>IA</given-names></name>
<name><surname>Ferreira</surname> <given-names>C</given-names></name>
<name><surname>Moura-Ramos</surname> <given-names>M</given-names></name>
<name><surname>Pinto-Gouveia</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood</article-title>. <source>Int J Colorectal Dis</source>. (<year>2017</year>) <volume>32</volume>:<page-range>651&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00384-017-2774-z</pub-id>, PMID: <pub-id pub-id-type="pmid">28185004</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sim</surname> <given-names>L</given-names></name>
<name><surname>Edelstein</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Cross-cultural differences in the links between familial support and strain in married and single adults&#x2019; Well-being</article-title>. <source>Pers Relat</source>. (<year>2025</year>) <volume>32</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/pere.70027</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McLean</surname> <given-names>LM</given-names></name>
<name><surname>Jones</surname> <given-names>JM</given-names></name>
<name><surname>Rydall</surname> <given-names>AC</given-names></name>
<name><surname>Walsh</surname> <given-names>A</given-names></name>
<name><surname>Esplen</surname> <given-names>MJ</given-names></name>
<name><surname>Zimmermann</surname> <given-names>C</given-names></name>
<etal/>
</person-group>. 
<article-title>A couples intervention for patients facing advanced cancer and their spouse caregivers: outcomes of a pilot study</article-title>. <source>Psychooncology</source>. (<year>2008</year>) <volume>17</volume>:<page-range>1152&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/pon.1319</pub-id>, PMID: <pub-id pub-id-type="pmid">18213694</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mehrizi</surname> <given-names>FZ</given-names></name>
<name><surname>Bagherian</surname> <given-names>S</given-names></name>
<name><surname>Bahramnejad</surname> <given-names>A</given-names></name>
<name><surname>Khoshnood</surname> <given-names>Z</given-names></name>
</person-group>. 
<article-title>The impact of logo-therapy on disease acceptance and self-awareness of patients undergoing hemodialysis; a pre-test-post-test research</article-title>. <source>BMC Psychiatry</source>. (<year>2022</year>) <volume>22</volume>:<fpage>670</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12888-022-04295-2</pub-id>, PMID: <pub-id pub-id-type="pmid">36316706</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>Q</given-names></name>
<name><surname>Zhu</surname> <given-names>C</given-names></name>
<name><surname>Feng</surname> <given-names>S</given-names></name>
<name><surname>Xu</surname> <given-names>L</given-names></name>
<name><surname>Hu</surname> <given-names>S</given-names></name>
<name><surname>Chen</surname> <given-names>H</given-names></name>
<etal/>
</person-group>. 
<article-title>Economic burden and health care access for patients with inflammatory bowel diseases in China: web-based survey study</article-title>. <source>J Med Internet Res</source>. (<year>2021</year>) <volume>23</volume>:<fpage>e20629</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2196/20629</pub-id>, PMID: <pub-id pub-id-type="pmid">33399540</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qiu</surname> <given-names>M</given-names></name>
<name><surname>Liu</surname> <given-names>C</given-names></name>
<name><surname>Zhen</surname> <given-names>J</given-names></name>
<name><surname>Liu</surname> <given-names>Z</given-names></name>
<name><surname>Wu</surname> <given-names>K</given-names></name>
<name><surname>Dong</surname> <given-names>W</given-names></name>
</person-group>. 
<article-title>Correlation analysis of disease course of inflammatory bowel disease patients with anxiety, depression, sleep disorders and quality of life</article-title>. <source>J Med Res</source>. (<year>2025</year>) <volume>25</volume>:<page-range>64&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.11969/j.issn.1673-548X.2025.06.012</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Izaguirre</surname> <given-names>MR</given-names></name>
<name><surname>Keefer</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Development of a self-efficacy scale for adolescents and young adults with inflammatory bowel disease</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. (<year>2014</year>) <volume>59</volume>:<fpage>29</fpage>&#x2013;<lpage>32</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/mpg.0000000000000357</pub-id>, PMID: <pub-id pub-id-type="pmid">24590216</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>H</given-names></name>
<name><surname>Han</surname> <given-names>M</given-names></name>
<name><surname>He</surname> <given-names>Y</given-names></name>
<name><surname>Wang</surname> <given-names>L</given-names></name>
<name><surname>Hou</surname> <given-names>W</given-names></name>
<name><surname>Guo</surname> <given-names>J</given-names></name>
<etal/>
</person-group>. 
<article-title>Influencing factors of anxiety and depression in mixed-age patients with inflammatory bowel disease: a systematic review and meta-analysis</article-title>. <source>Psychol Health Med</source>. (<year>2025</year>) <volume>9</volume>:<fpage>1</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13548506.2025.2564311</pub-id>, PMID: <pub-id pub-id-type="pmid">41067257</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Conley</surname> <given-names>S</given-names></name>
<name><surname>Redeker</surname> <given-names>N</given-names></name>
</person-group>. 
<article-title>A systematic review of self-management interventions for inflammatory bowel disease</article-title>. <source>J Nurs Scholarsh</source>. (<year>2016</year>) <volume>48</volume>:<page-range>118&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jnu.12189</pub-id>, PMID: <pub-id pub-id-type="pmid">26756193</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ji</surname> <given-names>X</given-names></name>
<name><surname>Ding</surname> <given-names>H</given-names></name>
<name><surname>Meng</surname> <given-names>Y</given-names></name>
</person-group>. 
<article-title>Study on the intervention effect of mindfulness-based stress reduction on postoperative cognitive dysfunction and psychological resilience in lung cancer patients</article-title>. <source>Front Neurol</source>. (<year>2025</year>) <volume>16</volume>:<elocation-id>1689318</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fneur.2025.1689318</pub-id>, PMID: <pub-id pub-id-type="pmid">41446877</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mendiolaza</surname> <given-names>M</given-names></name>
<name><surname>Ogundipe</surname> <given-names>T</given-names></name>
<name><surname>Arroyave-Villada</surname> <given-names>J</given-names></name>
<name><surname>Adeonigbagbe</surname> <given-names>O</given-names></name>
<name><surname>Gorbenko</surname> <given-names>K</given-names></name>
<name><surname>Keefer</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Investigating resilience in patients with IBD: preliminary insights for understanding disease-specific resilience skills</article-title>. <source>Front Psychol</source>. (<year>2024</year>) <volume>15</volume>:<elocation-id>1486401</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyg.2024.1486401</pub-id>, PMID: <pub-id pub-id-type="pmid">39606191</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Riggott</surname> <given-names>C</given-names></name>
<name><surname>Mikocka-Walus</surname> <given-names>A</given-names></name>
<name><surname>Gracie</surname> <given-names>DJ</given-names></name>
<name><surname>Ford</surname> <given-names>AC</given-names></name>
</person-group>. 
<article-title>Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis</article-title>. <source>Lancet Gastroenterol Hepatol</source>. (<year>2023</year>) <volume>8</volume>:<page-range>919&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s2468-1253(23)00186-3</pub-id>, PMID: <pub-id pub-id-type="pmid">37543040</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Trindade</surname> <given-names>IA</given-names></name>
<name><surname>Ferreira</surname> <given-names>C</given-names></name>
<name><surname>Pinto-Gouveia</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>The longitudinal effects of emotion regulation on physical and psychological health: A latent growth analysis exploring the role of cognitive fusion in inflammatory bowel disease</article-title>. <source>Br J Health Psychol</source>. (<year>2018</year>) <volume>23</volume>:<page-range>171&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/bjhp.12280</pub-id>, PMID: <pub-id pub-id-type="pmid">28980414</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/274932">Tam&#xe1;s Martos</ext-link>, University of Szeged, Hungary</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2068585">Barbara Horv&#xe1;t</ext-link>, University of Szeged, Hungary</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2868490">Farzad Goli</ext-link>, Isfahan University of Medical Sciences, Iran</p></fn>
</fn-group>
</back>
</article>